Foto: Research Program Cancer Research ©Copyright: Mario BengsImaging and Radiooncology

Health > Cancer Research - All Topics

Foto: Pharmaceutical production in the clean room ©Copyright: HZDR/Rainer WeisflogIn Germany, 500,000 people are diagnosed with cancer every year. New, faster, and primarily more gentle diagnostic and therapeutic procedures can help to fight the disease and to save lifes.

Cancer research at the HZDR addresses the following topics: The scientists conduct research, for example, on new radiopharmaceuticals for the diagnosis of cancer and for the characterization of cancer tissue and, as a further development, also investigate substances for the cancer therapy of tomorrow. Our research has already resulted in the development of new substances. Two radiopharmaceuticals are officially approved and registered pursuant to the pharmaceutical law. These substances, which are produced at the HZDR and subsequently distributed on the market, are needed for the detection of tumors and metastases with a PET camera (PET = Positron Emission Tomography). That is also possible in Dresden – patients can be examined utilizing a full-body scan PET/MRI system which is the first of its kind to have been approved for patients in Germany. HZDR scientists are further developing and improving these innovative imaging procedures which are used in oncology.

They are also investigating particle acceleration with the help of innovative laser technologies. The objective: Making proton-therapy centers smaller while, at the same time, lowering the costs through more powerful lasers and with pulsed magnetic fields. Researchers are also aiming on monitoring irradiation of patients with proton beams in real time.

The HZDR is part of the Competence Network for Radiation Research (KVSF, promoted by the BMBF). This alliance promotes the sustainability of competences in the field of radiation research, in particular, by fostering young scientists.

Important partners are the TU Dresden (Dresden University of Technology) and the University Hospital Carl Gustav Carus Dresden. We jointly operate the OncoRay Center. More information on collaborations with Dresden and Heidelberg partners


Objectives

  • Development and application of new technologies for the diagnosis and therapy of cancer
  • Establishment of laser-accelerated ions in radiation oncology
  • Monitoring and controlling tumor radiation in real time
  • Continued development of individualized and tolerable therapy forms

Press Releases


Involved HZDR institutes


Collaborations


Contacts


Publications

  • Büttner, M.; Melton, P.; Fietkau, R. et al.
    Successful implementation of online educational lectures of the German Society for Radiation Oncology (DEGRO)
    Strahlentherapie und Onkologie 200(2024), 151-158 (10.1007/s00066-023-02162-x)
  • Linge, A.; Patil, S.; Grosser, M. et al.
    The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts
    Radiotherapy and Oncology 191(2024), 110055 (10.1016/j.radonc.2023.110055)
  • Baumann, M.; Bacchus, C.; MC, A. et al.
    Clinical research for global needs of radiation oncology
    Radiotherapy and Oncology 190(2024), 110076 (10.1016/j.radonc.2023.110076)
  • Kirchner, J.; Plesca, I.; Rothe, R. et al.
    Type I conventional dendritic cells and CD8(+) T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients
    Frontiers in Immunology 15(2024), 1414298 (10.3389/fimmu.2024.1414298)
  • Baugh, J. N.; Veldhuijzen van Zanten, S.; Fiocco, M. et al.
    Treatment-related survival patterns in diffuse intrinsic pontine glioma using a historical cohort: A report from the European Society for Pediatric Oncology DIPG/DMG Registry
    Neuro-Oncology 6(2024), vdae155 (10.1093/noajnl/vdae155)
  • Knäusl, B.; Belotti, G.; Bertholet, J. et al.
    A review of the clinical introduction of 4D particle therapy research concepts
    Physics and Imaging in Radiation Oncology 29(2024), 100535 (10.1016/j.phro.2024.100535)
  • Mortensen, H. R.; Populaire, P.; Hoffmann, L. et al.
    Proton versus photon therapy for esophageal cancer – A trimodality strategy
    Radiotherapy and Oncology 190(2024), 109980 (10.1016/j.radonc.2023.109980)
  • Trnkova, P.; Dasu, A.; Placidi, L. et al.
    Patterns of practice of image guided particle therapy for cranio-spinal irradiation: A site specific multi-institutional survey of European Particle Therapy Network
    Physica Medica, European Journal of Medical Physics 123(2024), 103407 (10.1016/j.ejmp.2024.103407)
  • Philchenkov, A.; Dubrovska, A.
    Cancer Stem Cells as a Therapeutic Target: Current Clinical Development and Future Prospective
    Stem Cells 42(2024)3, 173-199 (10.1093/stmcls/sxad092)
  • Mehralivand, S.; Thomas, C.; Puhr, M. et al.
    New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium
    Journal of Translational Medicine 22(2024), 71 (10.1186/s12967-024-04878-5)
  • Beier, A.-M. K.; Ebersbach, C.; Siciliano, T. et al.
    Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer
    Oncogene 43(2024), 2038 (10.1038/s41388-024-03059-4)
  • Subbarayan, K.; Al-Samadi, A.; Schäfer, H. et al.
    Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors
    Cellular and Molecular Life Sciences 81(2024)473 (10.1007/s00018-024-05520-9)
  • Mehnert, E.; Möller, F.; Hofbauer, C. et al.
    Palliative care of proximal femur metastatic disease and osteolytic lesions: results following surgical and radiation treatment
    BMC Cancer 24(2024), 1431 (10.1186/s12885-024-13170-0)
  • Isaksson, L.; Mastroleo, F.; Vincini, M. et al.
    The emerging role of Artificial Intelligence in proton therapy: a review
    Critical Reviews in Oncology / Hematology 204(2024), 104485 (10.1016/j.critrevonc.2024.104485)
  • de Mendoza, A. M.; Michlikova, S.; Castro, P. S. et al.
    Generalized, sublethal damage-based mathematical approach for improved modeling of clonogenic survival curve flattening upon hyperthermia, radiotherapy, and beyond
    Physics in Medicine and Biology 70(2025), 025022 (10.1088/1361-6560/ada680)
  • Burger, E.-M.; Hauser, S.; Donat, C. et al.
    Investigation of a GPC-3-addressing peptide as potential radioligand for PET imaging of HCC
    Nuklearmedizin 63(2024)2, 154 (10.1055/s-0044-1782473)
  • Schädlich, J.; Ullrich, M.; Haase-Kohn, C. et al.
    Radioiodinated closo-dicarbadodecaborane(12)-based cyclooxygenase-2/5-lipoxygenase inhibitors
    EJNMMI Radiopharmacy and Chemistry 9(2024)Suppl 1, OP14 (10.1186/S41181-024-00294-8)
  • Trommer, J.; Kučka, J.; Vercellino, S. et al.
    Radiolabeling of M13 bacteriophages for in vivo imaging
    EJNMMI Radiopharmacy and Chemistry 9(2024), 65 (10.1186/s41181-024-00294-8)
  • Batool, A.; Duffin, R. N.; Burke, K. et al.
    Bismuth Oxide Nanorings: A Potential Material for Hyperthermia-Based Tumor Therapy
    ACS Applied Nano Materials 8(2025)1, 622-630 (10.1021/acsanm.4c05976)
  • Jarutyte, L.; Petr, J.; Turner, N. et al.
    Advantages and challenges of using arterial spin labelling MRI to monitor cerebral blood flow in multi-centre clinical trials of neurodegenerative disease: Experience from the RADAR study
    Cerebral Circulation, Cognition and Behavior 8(2025), 100376 (10.1016/j.cccb.2024.100376)
  • Eitler, J.; Rackwitz, W.; Wotschel, N. et al.
    CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation
    Journal for ImmunoTherapy of Cancer 12(2024), e008155 (10.1136/jitc-2023-008155)
  • Ahmed, M.; Beyreuther, E.; Gantz, S. et al.
    Design and dosimetric characterization of a transportable proton minibeam collimation system
    Frontiers in Oncology 14(2024), 1473625 (10.3389/fonc.2024.1473625)
  • Urbanovský, P.; David, T.; Hlinová, V. et al.
    Cross-bridged cyclam derivatives with bis(phosphinate) and phosphinate-phosphonate pendant arms (cb-BPC) as chelators for copper radioisotopes
    Organic & Biomolecular Chemistry (2025) (10.1039/D4OB01473A)
  • Selg, C.; Gordić, V.; Krajnović, T. et al.
    Re-design and evaluation of diclofenac-based carborane-substituted prodrugs and their anti-cancer potential
    Scientific Reports 14(2024), 30488 (10.1038/s41598-024-81414-x)
  • Markl, A. M.; Nieder, D.; Sandoval Bojorquez, D. I. et al.
    Heterogeneity of tumor biophysical properties and their potential role as prognostic markers.
    Cancer Heterogeneity and Plasticity 1(2024)2, 0011 (10.47248/chp2401020011)
  • Tinganelli, W.; Puspitasari-Kokko, A.; Sokol, O. et al.
    FLASH Bragg-peak irradiation with a therapeutic carbon ion beam: first in vivo results
    International Journal of Radiation Oncology Biology Physics (2025) (10.1016/j.ijrobp.2024.11.089)
  • Naseer, S.; Abelleira-Hervas, L.; Savani, D. et al.
    Traumatic Brain Injury Leads to Alterations in Contusional Cortical miRNAs Involved in Dementia
    Biomolecules 12(2022)10, 1457 (10.3390/biom12101457)
  • May, H. G.; Tsikonofilos, K.; Donat, C. et al.
    EEG hyperexcitability and hyperconnectivity linked to GABAergic inhibitory interneuron loss following traumatic brain injury
    Brain Communications 6(2024)6, fcae385 (10.1093/braincomms/fcae385)
  • Clegg, J.; Curvello, R.; Gabrielyan, A. et al.
    Tailoring metabolic activity assays for tumour-engineered 3D models
    Biomaterials Advances 167(2025), 214116 (10.1016/j.bioadv.2024.214116)
  • Liolios, C.; Bouziotis, D.; Sihver, W. et al.
    Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer
    ACS Medicinal Chemistry Letters 15(2024)11, 1970-1978 (10.1021/acsmedchemlett.4c00324)
  • Leikina, E.; Whitlock, J. M.; Melikov, K. et al.
    Formation of multinucleated osteoclasts depends on an oxidized species of cell surface-associated La protein
    eLife 13(2024)RP98665 (10.7554/eLife.98665)
  • Novy, Z.; Hajduova, K.; Petrik, M. et al.
    Preclinical assessment of enhanced blood retention and tumor uptake PSMA-targeting 225Ac-labeled radioconjugates
    EJNMMI Radiopharmacy and Chemistry 9(2024), OP30 (10.1186/s41181-024-00294-8)
  • Blei, M. K.; Drobot, B.; Stadlbauer, S. et al.
    Synthesis, stability determination and radiolabeling of new diazabenzene-based azamacrocycles with barium-131, actinium-225, lanthanum-133, and lead-212
    EJNMMI Radiopharmacy and Chemistry 9(2024), OP15 (10.1186/s41181-024-00294-8)
  • Palkowitsch, M.; Kaufmann, L.-M.; Hennings, F. et al.
    Variable-RBE-induced NTCP predictions for various side-effects following proton therapy for brain tumors – Identification of high-risk patients and risk mitigation
    Radiotherapy and Oncology 202(2025), 110590 (10.1016/j.radonc.2024.110590)
  • Vaxevanis, C.; Bachmann, M.; Seliger, B.
    Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy
    Journal for ImmunoTherapy of Cancer 12(2024), e009774 (10.1136/jitc-2024-009774)
  • Vehlow, A.; Lange, I.; Lagies, S. et al.
    Cytotoxic and Radiosensitizing Effects of European and African Propolis in 3D Lung Carcinoma Cell Cultures
    Anticancer Research 44(2024)11, 4801-4811 (10.21873/anticanres.17306)
  • Besso, M. J.; Bitto, V.; Koi, L. et al.
    Transcriptomic and epigenetic landscape of nimorazole-enhanced radiochemotherapy in head and neck cancer
    Radiotherapy and Oncology 199(2024), 110348 (10.1016/j.radonc.2024.110348)
  • Gündel, D.; Teodoro, R.; Ludwig, F.-A. et al.
    Development and Evaluation of Deuterated [18F]JHU94620 Isotopologues for the Non-invasive Assessment of the Cannabinoid type 2 Receptor in Brain
    EJNMMI Radiopharmacy and Chemistry 9(2024), 91 (10.1186/s41181-024-00319-2)
  • Peters, N.; Taasti, V. T.; Ackermann, B. et al.
    Response to “Letter regarding Consensus guide on CT-based prediction of stopping-power ratio using a Hounsfield look-up table for proton therapy”
    Radiotherapy and Oncology 190(2024), 109961 (10.1016/j.radonc.2023.109961)
  • Brunner, J.; Langgartner, L.; Danhel, H. et al.
    Dosimetric characteristics of 3D-printed and epoxy-based materials for particle therapy phantoms
    Frontiers in Physics 12(2024), 1323788 (10.3389/fphy.2024.1323788)
  • Nazary, H.; Metternich, M.; Schumacher, D. et al.
    Towards ion stopping power experiments with the laser-driven LIGHT beamline
    Journal of Plasma Physics 90(2024)3, 905900302 (10.1017/S0022377824000576)
  • Scott, P.; Penuelas, I.; Rey, A. et al.
    Highlight selection of radiochemistry and radiopharmacy developments by editorial board
    EJNMMI Radiopharmacy and Chemistry 9(2024), 67 (10.1186/s41181-024-00296-6)
  • Metzger, G.; Bayerl, C.; Rogasch, J. et al.
    68Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapy
    Theranostics 14(2024)11, 4184-4197 (10.7150/thno.95329)
  • Bela Andela, S.; Amthauer, H.; Furth, C. et al.
    Quantitative PSMA-PET parameters in localized prostate cancer: prognostic and potential predictive value
    Radiation Oncology 19(2024), 97 (10.1186/s13014-024-02483-w)
  • Oborn, B. M.; Semioshkina, E.; van der Kraaij, E. et al.
    Simulation and experimental benchmarking of a proton pencil beam scanning nozzle for development of MRI-guided proton therapy
    Medical Physics 51(2024)9, 6196-6205 (10.1002/mp.17279)
  • Padrela, B. E.; Slivka, M.; Sneve, M. H. et al.
    Blood-brain barrier water permeability across the adult lifespan: A multi-echo ASL study
    Neurobiology of Aging 147(2025), 176-186 (10.1016/j.neurobiolaging.2024.12.012)
  • Schott, M.; Vehlow, A.; Benka, M. et al.
    Aqueous extracts from Dioscorea sansibarensis Pax show cytotoxic and radiosensitizing potential in 3D growing HPV-negative and HPV-positive human head and neck squamous cell carcinoma models
    Biomedicine and Pharmacotherapy 179(2024), 117305 (10.1016/j.biopha.2024.117305)
  • Doctor, A.; Laube, M.; Meister, S. et al.
    Combined PET radiotracer approach reveals insights into stro-mal cell-induced metabolic changes in pancreatic cancer in vitro and in vivo
    Cancers 16(2024), 3393 (10.3390/cancers16193393)
  • Azizova, A.; Wamelink, I. J. H. G.; Prysiazhniuk, Y. et al.
    Human Performance in Predicting Enhancement Quality of Gliomas Using Gadolinium-Free MRI Sequences
    Journal of Neuroimaging 34(2024)6, 673-693 (10.1111/jon.13233)
  • Zegers, C.; Swinnen, A.; Roumen, C. et al.
    High precision stereotactic irradiation for focal drug-resistant epilepsy versus standard treatment: a randomized waitlist-controlled trial (the PRECISION-trial)
    Trials 25(2024), 334 (10.1186/s13063-024-08168-9)
  • Witzmann, K.; Raschke, F.; Wesemann, T. et al.
    Diffusion decrease in normal-appearing white matter structures following photon or proton irradiation indicates differences in regional radiosensitivity
    Radiotherapy and Oncology 199(2024), 110459 (10.1016/j.radonc.2024.110459)
  • Shahzadi, I.; Seidlitz, A.; Beuthien-Baumann, B. et al.
    Radiomics for the detection of residual tumour status after surgery and patient outcome prediction after chemoradiotherapy in newly diagnosed glioblastoma based on [11C] methionine PET and T1c-w MRI
    Scientific Reports 14(2024), 4576 (10.1038/s41598-024-55092-8)
  • Igbo, B. T.; Jentsch, C.; Linge, A. et al.
    Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients
    Strahlentherapie und Onkologie 200(2024), 595-604 (10.1007/s00066-024-02234-6)
  • Grau, C.; Dasu, A.; Troost, E. G. C. et al.
    Towards a European prospective data registry for particle therapy
    Radiotherapy and Oncology 196(2024), 110293 (10.1016/j.radonc.2024.110293)
  • Erb, H.; Polishchuk, N.; Stasyk, O. et al.
    Glutamine metabolism and prostate cancer
    Cancers 16(2024)16, 2871 (10.3390/cancers16162871)
  • Sihver, W.; Walther, M.; Ullrich, M. et al.
    Cyclohexanediamine triazole (CHDT)-functionalization enables labeling of target molecules with Al18F / 68Ga / 111In
    Bioconjugate Chemistry 35(2024)9, 1402-1416 (10.1021/acs.bioconjchem.4c00313)
  • Krönke, T.; Kopka, K.; Mamat, C.
    Enhancing the radionuclide theranostic concept through the radiohybrid approach
    RSC Medicinal Chemistry (2025) (10.1039/d4md00591k)
  • Rothe, R.; Xu, Y.; Wodtke, J. et al.
    Programmable Release of Chemotherapeutics from Ferrocene-based Injectable Hydrogels Slows Melanoma Growth
    Advanced Healthcare Materials 13(2024)27, 2400265 (10.1002/adhm.202400265)
  • Ullrich, M.; Wodtke, R.; Brandt, F. et al.
    The heterobivalent (SSTR2/albumin) radioligand [67Cu]cCu-NODAGA-cLAB4-TATE enables efficient somatostatin receptor radionuclide theranostics
    Theranostics 14(2024)14, 5371-5387 (10.7150/thno.100091)
  • Samarzija, I.; Lukiyanchuk, V.; Lončarić, M. et al.
    The extracellular matrix component Perlecan/HSPG2 regulates radioresistance in prostate cancer cells
    Frontiers in Cell and Developmental Biology 12(2024), 1452463 (10.3389/fcell.2024.1452463)
  • Maus, J.; Nikulin, P.; Hofheinz, F. et al.
    Deep learning based bilateral filtering for edge-preserving denoising of respiratory-gated PET
    EJNMMI Physics 11(2024), 58 (10.1186/s40658-024-00661-z)
  • Azizova, A.; Prysiazhniuk, Y.; Wamelink, I. J. H. G. et al.
    Preoperative Prediction of Diffuse Glioma Type and Grade in Adults: a Gadolinium-Free MRI-Based Decision Tree
    European Radiology (2025) (10.1007/s00330-024-11140-5)
  • Marie Benko, L.; Misko, V. R.; Baraban, L. et al.
    Janus Particles in Acoustofluidic Setup: The Interplay between Self-Propulsion and Acoustic Trapping
    Micro 4(2024)1, 185-195 (10.3390/micro4010013)
  • Sonam, S.; Jelača, S.; Laube, M. et al.
    Carborane Conjugates with Ibuprofen, Fenoprofen and Flurbiprofen: Synthesis, Characterization, COX Inhibition Potential and In Vitro Activity
    ChemMedChem 20(2025), e202400018 (10.1002/cmdc.202400018)
  • Ratliff, H. N.; Kögler, T.; Pausch, G. et al.
    The Backscatter Gating method for time, energy, and position resolution characterization of long form factor organic scintillators
    Journal of Instrumentation 19(2024)07, P07002 (10.1088/1748-0221/19/07/P07002)
  • Wang, J.; Wang, T.; Mou, T. et al.
    Novel 18F-labeled benzimidazolone-based radioligands as highly selective sigma-2 receptor probes for tumor imaging
    Journal of Medicinal Chemistry 67(2024)19, 17392-17406 (10.1021/acs.jmedchem.4c01315)
  • Schneider, M.; Schilz, J.; Schürer, M. et al.
    SAPPHIRE - Establishment of Small Animal Proton and PHoton Image-guided Radiation Experiments
    Physics in Medicine and Biology 69(2024)97, 095020 (10.1088/1361-6560/ad3887)
  • Kaushik, S.; Stützer, K.; Ödén, J. et al.
    Adaptive intensity modulated proton therapy using 4D robust planning: a proof-of-concept for the application of dose mimicking approach
    Physics in Medicine and Biology 69(2024)18, 185010 (10.1088/1361-6560/ad75e0)
  • Dijsselhof, M. B. J.; Holtrop, J.; James, S.-N. et al.
    Associations of life-course cardiovascular risk factors with late-life cerebral haemodynamics
    Journal of Cerebral Blood Flow and Metabolism (2025) (10.1177/0271678X241301261)
  • Samimi, R.; Kamali-Asl, A.; Ahmadyar, Y. et al.
    Dual time-point [18F]FDG PET imaging for quantification of metabolic uptake rate: Evaluation of a simple, clinically feasible method
    Physica Medica, European Journal of Medical Physics 121(2024), 103336 (10.1016/j.ejmp.2024.103336)
  • Brühlmann, S. A.; Walther, M.; Blei, M. K. et al.
    Scalability Study on [133La]LaCl3 Production with a Focus on Potential Clinical Applications
    EJNMMI Radiopharmacy and Chemistry 9(2024)1, 60 (10.1186/s41181-024-00292-w)
  • Makarevich, K.; Schellhammer, S.; Pausch, G. et al.
    Proton bunch monitors for the clinical translation of prompt gamma-ray timing
    Physics in Medicine and Biology 69(2024), 225013 (10.1088/1361-6560/ad8c96)
  • Hueso-González, F.; Berthold, J.; Wohlfahrt, P. et al.
    Inter-center comparison of proton range verification prototypes with an anthropomorphic head phantom
    Physics in Medicine and Biology 69(2024)22, 225010 (10.1088/1361-6560/ad8856)
  • Schniewind, I.; José Besso, M.; Klicker, S. et al.
    Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer
    Cancers 16(2024), 730 (10.3390/cancers16040730)
  • Boutier, H.; Rodrigues Loureiro, L. R.; Hoffmann, L. et al.
    UniCAR T-cell potency – A matter of affinity between Adaptor Molecules and Adaptor CAR T-cells?
    International Journal of Molecular Sciences 25(2024)13, 7242 (10.3390/ijms25137242)
  • Blei, M. K.; Drobot, B.; Stadlbauer, S. et al.
    Synthese, Stabilitätsbestimmung und Radiomarkierung neuer Pym-Azamakrozyklen mit Barium-131, Actinium-225, Lanthan-133, und Blei-212
    Nuklearmedizin 63(2024), 91 (10.1055/s-0044-1782286)
  • Krönke, T.; Zarschler, K.; Reissig, F. et al.
    Iod-123-basierte Radiohybridkonjugate als diagnostisches Match zur zielgerichteten Alphatherapie mit Actinium-225
    Nuklearmedizin 63(2024), 111 (10.1055/s-0044-1782344)
  • Tee, M.; Padrela, B.; Dupeyron, M. et al.
    Associations between Potential Risk Factors and Blood-brain Barrier Water Permeability in Middle-aged and Older Adults
    Journal of Alzheimer's Disease (2025) (10.1177/13872877251314138)
  • Wamelink, I.; Azizova, A.; Booth, T. et al.
    Rebuttal to the LET to be paired with RAD-24-0653, entitled Gadolinium Reduction in Brain Tumor Imaging: A Paradigm Shift in Diagnostic Strategies
    Radiology (2024) (10.1148/radiol.240653)
  • Starke, S.; Kieslich, A. M.; Palkowitsch, M. et al.
    A deep-learning-based surrogate model for Monte-Carlo simulations of the linear energy transfer in primary brain tumor patients treated with proton-beam radiotherapy
    Physics in Medicine and Biology 69(2024), 165034 (10.1088/1361-6560/ad64b7)
  • Prysiazhniuk, Y.; Server, A.; Leske, H. et al.
    Diffuse glioma molecular profiling with Arterial Spin Labeling and Dynamic Susceptibility Contrast perfusion MRI: a comparative study
    Neuro-Oncology Advances 6(2024)1, vdae113 (10.1093/noajnl/vdae113)
  • Padrela, B.; Mahroo, A.; Tee, M. et al.
    Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer’s disease (DEBBIE-AD): a prospective observational multicohort study protocol
    BMJ Open 14(2024)3, e081635 (10.1136/bmjopen-2023-081635)
  • Kubeil, M.; Neuber, C.; Starke, M. et al.
    64Cu tumor labeling with hexadentate picolinic acid-based bispidine immunoconjugates
    Chemistry - A European Journal 30(2024), e202400366 (10.1002/chem.202400366)
  • Weber, T.; Krönke, T.; Köckerling, M. et al.
    Towards the Stable Binding of Mercury: Synthesis and Functionalization of Dibenzyldiazabicyclononane Scaffolds
    European Jounal of Organic Chemistry 27(2024)25, e202400258 (10.1002/ejoc.202400258)
  • Toyohara, J.; Vugts, D.; Kiß, O. et al.
    Highlight selection of radiochemistry and radiopharmacy developments by editorial board
    EJNMMI Radiopharmacy and Chemistry 9(2024), 42 (10.1186/s41181-024-00268-w)
  • Paschoal, A. M.; Woods, J. G.; Pinto, J. et al.
    Reproducibility of Arterial Spin Labeling Cerebral Blood Flow image processing: A Report of The ISMRM Open Science Initiative for Perfusion Imaging and the ASL MRI Challenge
    Magnetic Resonance in Medicine 92(2024), 836-852 (10.1002/mrm.30081)
  • Cegla, P.; Hofheinz, F.; Czepczyński, R. et al.
    Value of [18F] FDG PET/CT parameters of the primary tumor in assessing overall survival in NSCLC patients with cN1-cN3 lymph nodes involvement
    Reports of Practical Oncology and Radiotherapy 29(2024)1, 97-102 (10.5603/rpor.99360)
  • Abdelfatah Saleh Hassan, H. A.; Mitwasi, N.; Rodrigues Loureiro, L. R. et al.
    RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma
    Cancer Gene Therapy 31(2024), 1323-1334 (10.1038/s41417-024-00766-8)
  • Bigos, K.; Quiles, C.; Lunj, S. et al.
    Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours
    Frontiers in Oncology 14(2024), 1331355 (10.3389/fonc.2024.1331355)
  • Mamat, C.; Köckerling, M.
    The crystal structure of (2-diphenylphosphanylphenyl) 2-[7-(dimethylamino)-2-oxochromen-4-yl]acetate, C31H26NO4P
    Zeitschrift für Kristallographie - New Crystal Structures 239(2024), 511 (10.1515/ncrs-2024-0065)
  • Maisonial-Besset, A.; Kryza, D.; Kopka, K. et al.
    Improved automated one-pot two-step radiosynthesis of (S)-[18F]FETrp, a radiotracer for PET imaging of indoleamine 2,3-dioxygenase 1 (IDO1)
    European Journal of Nuclear Medicine and Molecular Imaging 9(2024), 28 (10.1186/s41181-024-00256-0)
  • Peng, X.; Janićijević, Ž.; Lemm, S. et al.
    Impact of Viscosity on Human Hepatoma Spheroids in Soft Core-Shell Microcapsules
    Advanced Healthcare Materials 11(2024)13, 2302609 (10.1002/adhm.202302609)
  • Zhang, Y.; Trnkova, P.; Toshito, T. et al.
    A survey of practice patterns for real-time intrafractional motion-management in particle therapy
    Physics and Imaging in Radiation Oncology 26(2023), 100439 (10.1016/j.phro.2023.100439)
  • Trnkova, P.; Zhang, Y.; Toshito, T. et al.
    A survey of practice patterns for adaptive particle therapy for interfractional changes
    Physics and Imaging in Radiation Oncology 26(2023), 100442 (10.1016/j.phro.2023.100442)
  • Tawk, B.; Rein, K.; Schwager, C. et al.
    DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
    Clinical Cancer Research 29(2023)16, 3051-3064 (10.1158/1078-0432.CCR-22-3790)
  • Peters, N.; Trier Taasti, V.; Ackermann, B. et al.
    Consensus guide on CT-based prediction of stopping-power ratio using a Hounsfield look-up table for proton therapy
    Radiotherapy and Oncology 184(2023), 109675 (10.1016/j.radonc.2023.109675)
  • Vrou Offersen, B.; Aznar, M. C.; Bacchus, C. et al.
    The role of ESTRO guidelines in achieving consistency and quality in clinical radiation oncology practice
    Radiotherapy and Oncology 179(2023), 109446 (10.1016/j.radonc.2022.109446)
  • Leichtle, F.; Betzler, A. C.; Eizenberger, C. et al.
    Influence of Bruton’s Tyrosine Kinase (BTK) on Epithelial–Mesenchymal Transition (EMT) Processes and Cancer Stem Cell (CSC) Enrichment in Head and Neck Squamous Cell Carcinoma (HNSCC)
    International Journal of Molecular Sciences 24(2023)17, 13133 (10.3390/ijms241713133)
  • Koi, L.; Bitto, V.; Weise, C. et al.
    Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts
    Journal of Translational Medicine 21(2023), 576 (10.1186/s12967-023-04439-2)
  • Klusa, D.; Lohaus, F.; Franken, A. et al.
    Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy
    International Journal of Cancer 152(2023), 2639-2654 (10.1002/ijc.34457)
  • Gantz, S.; Karsch, L.; Pawelke, J. et al.
    Direct visualization of proton beam irradiation effects in liquids by MRI
    Proceedings of the National Academy of Sciences of the United States of America 120(2023)23, e2301160120 (10.1073/pnas.2301160120)
  • Franke, F.; Michlikova, S.; Aland, S. et al.
    Efficient Radial-Shell Model for 3D Tumor Spheroid Dynamics with Radiotherapy
    Cancers 15(2023), 5645 (10.3390/cancers15235645)
  • Corti, C.; Cobanaj, M.; Dee, E. C. et al.
    Artificial intelligence in cancer research and precision medicine: Applications, limitations and priorities to drive transformation in the delivery of equitable and unbiased care
    Cancer Treatment Reviews 112(2023), 102498 (10.1016/j.ctrv.2022.102498)
  • Baumann, M.; Bacchus, C.; Aznar, M. C. et al.
    Are hybrid conferences the new standard?
    Radiotherapy and Oncology 128(2023), 109695 (10.1016/j.radonc.2023.109695)
  • Runge, R.; Reissig, F.; Herzog, N. et al.
    Combining Cisplatin with Different Radiation Qualities—Interpretation of Cytotoxic Effects In Vitro by Isobolographic Analysis
    Pharmaceuticals 16(2023)12, 1720 (10.3390/ph16121720)
  • Rahbar, K.; Wagner, S.; Schaeg, F. et al.
    First Experiences with the new 99mTc labelled PSMA ligand [99mTc]TcO-ABX474 in Patients with Advanced Prostate Cancer Prior to PSMA targeted Radioligand Therapy
    Journal of Nuclear Medicine 66(2024)suppl 2, 241711
  • Curvello, R.; Berndt, N.; Hauser, S. et al.
    Recreating metabolic interactions of the tumour microenvironment
    Trends in Endocrinology & Metabolism 35(2024), 518-532 (10.1016/j.tem.2023.12.005)
  • Berthold, J.; Bertschi, S.; Pietsch, J. et al.
    Clinical translation of Prompt-Gamma-Imaging for treatment verification in online-adaptive proton therapy: Overview of achievements and outlook
    International Journal of Particle Therapy 12(2024)Supplement, 100508 (10.1016/j.ijpt.2024.100508)
  • Towers, R.; Trombello, L.; Fusenig, M. et al.
    Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T cell function while promoting a senescence-associated phenotype
    Cancer Immunology, Immunotherapy 73(2024), 8 (10.1007/s00262-023-03594-1)
  • Miederer, M.; Benešová-Schäfer, M.; Mamat, C. et al.
    Alpha-emitting Radionuclides: Current Status and Future Perspectives
    Pharmaceuticals 17(2024), 76 (10.3390/ph17010076)
  • Janićijević, Ž.; Huang, T.; Sandoval Bojorquez, D. I. et al.
    Design and Development of Transient Sensing Devices for Healthcare Applications
    Advanced Science 11(2024)20, 2307232 (10.1002/advs.202307232)
  • Ludwig, F.-A.; Laurini, E.; Schmidt, J. et al.
    [¹⁸F]Fluspidine – a PET tracer for imaging of σ1 receptors in the central nervous system
    Pharmaceuticals 17(2024)166, 1-21 (10.3390/ph17020166)
  • Weiß, A.; Löck, S.; Xu, T. et al.
    Prediction of radiation pneumonitis using the effective α/β of lungs and heart in NSCLC patients treated with proton beam therapy
    Radiotherapy and Oncology 190(2024), 110013 (10.1016/j.radonc.2023.110013)
  • Samuels, M.; Falkenius, J.; Bar-Ad, V. et al.
    A Phase I Study of the DNA-PK Inhibitor Peposertib in Combination with Radiotherapy with or without Cisplatin in Patients with Advanced Head and Neck Tumors
    International Journal of Radiation Oncology Biology Physics 118(2024)3, 743-756 (10.1016/j.ijrobp.2023.09.024)
  • Mazzola, G. C.; Bergamaschi, L.; Vincini, M. et al.
    Patients’ needs in Proton Therapy: a survey among 10 European Facilities
    Clinical and Translational Radiation Oncology 43(2023), 100670 (10.1016/j.ctro.2023.100670)
  • Lococo, F.; Boldrini, L.; Diepriye, C.-D. et al.
    Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study
    BMC Cancer 23(2023), 540 (10.1186/s12885-023-10997-x)
  • Elkhamisy, S. A.; Valentini, C.; Lattermann, A. et al.
    Normo-or hypo-fractionated photon or proton radiotherapy in the management of locally advanced unresectable pancreatic cancer: a systematic review
    Cancers 15(2023), 3771 (10.3390/cancers15153771)
  • Bookbinder, A.; Bobić, M.; Sharp, G. C. et al.
    An Operator-Independent Quality Assurance System for Automatically Generated Structure Sets
    Physics in Medicine and Biology 69(2024), 175003 (10.1088/1361-6560/ad6742)
  • Kreller, M.; Walther, M.; Brühlmann, S. A. et al.
    Production of medical radionuclides in the Center for Radiopharmaceutical Tumor Research – a status report
    Instruments 8(2024)1, 10 (10.3390/instruments8010010)
  • Zhao, X.; Kolbinger, F. R.; Distler, M. et al.
    Portable Droplet-Based Real-Time Monitoring of Pancreatic α-Amylase in Postoperative Patients
    Biosensors and Bioelectronics 251(2024), 116034 (10.1016/j.bios.2024.116034)
  • Szöllősi, D.; Hajdrik, P.; Tordai, H. et al.
    Molecular imaging of bacterial outer membrane vesicles based on bacterial surface display
    Scientific Reports 13(2023), 18752 (10.1038/s41598-023-45628-9)
  • Gorodetska, I.; Offerman, A.; Püschel, J. et al.
    ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription
    Theranostics 14(2024)2, 714-737 (10.7150/thno.88057)
  • Drewitz, L.; Kegler, A.; Arndt, C. et al.
    Development Of A Novel ACE2 Decoy For Both SARS-CoV-2 Variant Neutralization And Infected Cell Elimination Via Unmodified Or CAR Modified Immune Cells
    Human Gene Therapy 34(2023), 92 (10.1089/hum.2023.29252.abstracts)
  • Brühlmann, S. A.; Walther, M.; Kopka, K. et al.
    Production of the PET radionuclide 61Cu via the 62Ni(p,2n)61Cu Nuclear Reaction
    EJNMMI Radiopharmacy and Chemistry 9(2024)1, 3 (10.1186/s41181-023-00233-z)
  • Gambetta, V.; Fredriksson, A.; Menkel, S. et al.
    The partial adaptation strategy for online-adaptive proton therapy: a proof of concept study in head and neck cancer patients
    Medical Physics 51(2024)8, 5572-5581 (10.1002/mp.17178)
  • Misko, V. R.; Baraban, L.; Makarov, D. et al.
    Selecting active matter according to motility in an acoustofluidic setup: Self-propelled particles and sperm cells
    Soft Matter 19(2023), 8635 (10.1039/D3SM01214J)
  • Horst, F. E.
    Calorimetry as a tool to improve the dosimetric accuracy in novel radiotherapy modalities
    Physics and Imaging in Radiation Oncology 28(2023), 100516 (10.1016/j.phro.2023.100516)
  • Horst, F. E.; Bodenstein, E.; Brand, M. et al.
    Dose and dose rate dependence of the tissue sparing effect at ultra-high dose rate studied for proton and electron beams using the zebrafish embryo model.
    Radiotherapy and Oncology 194(2024), 110197 (10.1016/j.radonc.2024.110197)
  • Janićijević, Ž.; Nguyen Le, T. A.; Baraban, L.
    Extended-gate field-effect transistor chemo- and biosensors: State of the art and perspectives
    Next Nanotechnology 3–4(2023), 100025 (10.1016/j.nxnano.2023.100025)
  • Wodtke, R.; Laube, M.; Hauser, S. et al.
    Preclinical evaluation of an ¹⁸F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2
    EJNMMI Radiopharmacy and Chemistry 9(2024)1, 1 (10.1186/s41181‑023‑00231‑1)
  • Novgorodova, O.; Glatte, A.; Hentges, R. et al.
    Characterisation of a high granularity multi-channel prompt γ-ray detection system prototype for proton range verification based on the PETsys TOFPET2 ASIC
    Journal of Instrumentation 19(2024), P02030 (10.1088/1748-0221/19/02/P02030)
  • Craig, A.; Kogler, J.; Laube, M. et al.
    Preparation of 18F-Labeled Tracers Targeting Fibroblast Activation Protein via Sulfur [18F]Fluoride Exchange Reaction
    Pharmaceutics 15(2023)12, 2749 (10.3390/pharmaceutics15122749)
  • Patt, M.; Decristoforo, C.; de Martini, A. et al.
    The revision of the pharmaceutical legislation – it is time to act for nuclear medicine in Europe
    European Journal of Nuclear Medicine and Molecular Imaging 51(2023), 20-24 (10.1007/s00259-023-06472-1)
  • Broghammer, F.; Gouda, M.; Korovina, I. et al.
    Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome
    Molecular Cancer 23(2024), 39 (10.1186/s12943-024-01954-8)
  • González Soto, K. E.; Rodrigues Loureiro, L. R.; Bartsch, T. et al.
    Targeting colorectal cancer cells using AND-gated Adaptor RevCAR T-cells
    Frontiers in Immunology 14(2023), 1302354 (10.3389/fimmu.2023.1302354)
  • Krutzek, F.; Donat, C.; Stadlbauer, S.
    Chelator Impact: Investigating the Pharmacokinetic Behavior of Copper-64 Labeled PD-L1 Radioligands
    EJNMMI Radiopharmacy and Chemistry 9(2024), 14 (10.1186/s41181-024-00243-5)
  • Janićijević, Ž.; Nguyen Le, T. A.; Alsadig, A. et al.
    Methods gold standard in clinic millifluidics multiplexed extended gate field-effect transistor biosensor with gold nanoantennae as signal amplifiers
    Biosensors and Bioelectronics 241(2023), 115701 (10.1016/j.bios.2023.115701)
  • Rodrigues Loureiro, L. R.; Hoffmann, L.; Neuber, C. et al.
    Immunotheranostic target modules for imaging and navigation of UniCAR T-cells to strike FAP-expressing cells and the tumor microenvironment
    Journal of Experimental & Clinical Cancer Research 42(2023), 341 (10.1186/s13046-023-02912-w)
  • Zhao, X.; Ruelens, P.; Farr, A. D. et al.
    Population dynamics of cross-protection against β-lactam antibiotics in droplet microreactors
    Frontiers in Microbiology 14(2023), 1294790 (10.3389/fmicb.2023.1294790)
  • Zschaeck, S.; Klinger, B.; van den Hoff, J. et al.
    Combination of tumor asphericity and an extracellular matrix-related prognostic gene signature in non-small cell lung cancer patients
    Scientific Reports 13(2023), 20840 (10.1038/s41598-023-46405-4)
  • Korde, A.; Patt, M.; Selivanova, S. et al.
    Position Paper to facilitate patient access to radiopharmaceuticals - considerations for a suitable pharmaceutical regulatory framework
    EJNMMI Radiopharmacy and Chemistry 9(2024)1, 2 (10.1186/s41181-023-00230-2)
  • Klotz, D. M.; Schwarz, F.; Dubrovska, A. et al.
    Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer.
    Cancers 15(2023)15, 3774 (10.3390/cancers15153774)
  • Kubeil, M.; Suzuki, Y.; Casulli, M. A. et al.
    Exploring the Potential of Nanogels: From Drug Carriers to Radiopharmaceutical Agents
    Advanced Healthcare Materials 13(2023)1, 2301404 (10.1002/adhm.202301404)
  • Poldrack, R. A.; Markiewicz, C. J.; Appelhoff, S. et al.
    The Past, Present, and Future of the Brain Imaging Data Structure (BIDS)
    Imaging Neuroscience 2(2024), 1-19 (10.1162/imag_a_00103)
  • Korovina, I.; Elser, M.; Borodins, O. et al.
    β1 integrin mediates unresponsiveness to PI3Kα inhibition for radiochemosensitization of 3D HNSCC models
    Biomedicine and Pharmacotherapy 171(2024), 116217 (10.1016/j.biopha.2024.116217)
  • Kopp, I.; Cieslik, P.; Anger, K. et al.
    Bispidine Chelators for Radiopharmaceutical Applications with Lanthanide, Actinide and Main Group Metal Ions
    Inorganic Chemistry 62(2023)50, 20754-20768 (10.1021/acs.inorgchem.3c02340)
  • Pasternak, M.; Mirza, S.; Luciw, N. et al.
    Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results
    Alzheimer's & Dementia 20(2024)5, 3525-3542 (10.1002/alz.13750)
  • Krutzek, F.; Donat, C.; Stadlbauer, S.
    Exploring Hydrophilic PD-L1 Radiotracers Utilizing Phosphonic Acids: Insights Into Unforeseen Pharmacokinetics
    International Journal of Molecular Sciences 24(2023)20, 15088 (10.3390/ijms242015088)
  • Nenoff, L.; Amstutz, F.; Murr, M. et al.
    Review and recommendations on deformable image registration uncertainties for radiotherapy applications
    Physics in Medicine and Biology 68(2023), 24TR01 (10.1088/1361-6560/ad0d8a)
  • Wang, T.; Wang, J.; Chen, L. et al.
    Development of a Highly Specific 18F-labeled Radioligand for Imaging of Sigma-2 Receptor in Brain Tumor
    Journal of Medicinal Chemistry 66(2023)18, 12840-12857 (10.1021/acs.jmedchem.3c00735)
  • Cegla, P.; Hofheinz, F.; Burchardt, E. et al.
    Asphericity derived from [18F]FDG PET as a new prognostic parameter in cervical cancer patients
    Scientific Reports 13(2023)1, 8423 (10.1038/s41598-023-35191-8)
  • Maria Sag, S. J.; Menhart, K.; Hitzenbichler, F. et al.
    18F-FDG PET/CT-derived total lesion glycolysis predicts abscess formation in patients with surgically confirmed infective endocarditis: Results of a retrospective study at a tertiary center
    Journal of Nuclear Cardiology 30(2023), 2400-2414 (10.1007/s12350-023-03285-5)
  • Starke, S.; Zwanenburg, A.; Leger, K. et al.
    Multitask Learning with Convolutional Neural Networks and Vision Transformers Can Improve Outcome Prediction for Head and Neck Cancer Patients
    Cancers 15(2023)19, 4897 (10.3390/cancers15194897)
  • Elser, M.; Vehlow, A.; Juratli, T. et al.
    Simultaneous inhibition of discoidin domain receptor 1 and integrin αVβ3 radiosensitizes human glioblastoma cells
    American Journal of Cancer Research 13(2023)10, 4597-4612
  • Samimi, R.; Shiri, I.; Ahmadyar, Y. et al.
    Radiomics predictive modeling from dual-time-point FDG PET Ki parametric maps: application to chemotherapy response in lymphoma
    EJNMMI Research 13(2023)1, 70 (10.1186/s13550-023-01022-0)
  • Krutzek, F.; Donat, C.; Ullrich, M. et al.
    Design, Synthesis, and Biological Evaluation of Small Molecule Based Radioligands with Improved Pharmacokinetic Properties for Imaging of Programmed Death Ligand 1
    Journal of Medicinal Chemistry 66(2023)23, 15894-15915 (10.1021/acs.jmedchem.3c01355)
  • Azizova, A.; Prysiazhniuk, Y.; Wamelink, I. J. H. G. et al.
    Ten years of VASARI glioma features: Systematic review and meta-analysis of their impact and performance
    American Journal of Neuroradiology 45(2024)8, 1053-1062 (10.3174/ajnr.A8274)
  • Yaromina, A.; Koi, L.; Schuitmaker, L. et al.
    Overcoming radioresistance with the hypoxia-activated prodrug CP-506: A pre-clinical study of local tumour control probability
    Radiotherapy and Oncology 186(2023), 109738 (10.1016/j.radonc.2023.109738)
  • Lai, T. H.; Wenzel, B.; Dukic-Stefanovic, S. et al.
    Radiosynthesis and biological evaluation of [¹⁸F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in gliomas
    European Journal of Nuclear Medicine and Molecular Imaging 51(2024), 1085-1096 (10.1007/s00259-023-06515-7)
  • Schellhammer, S.; Meric, I.; Löck, S. et al.
    Hybrid treatment verification based on prompt gamma-rays and fast neutrons: Multivariate modelling for proton range determination
    Frontiers in Physics 11(2023), 1295157 (10.3389/fphy.2023.1295157)
  • Xia, P.; Dubrovska, A.
    CD98 heavy chain as a prognostic biomarker and target for cancer treatment
    Frontiers in Oncology 13(2023), 1251100 (10.3389/fonc.2023.1251100)
  • Blei, M. K.; Drobot, B.; Kretzschmar, J. et al.
    Determination of Association Constants of Macropa-based Chelators for the Stable Complexation of Barium-131 and Lanthanum-133
    Nuclear Medicine and Biology 126-127(2023)S1, S245-S246 (10.1016/j.nucmedbio.2023.108722)
  • Blei, M. K.; Drobot, B.; Kretzschmar, J. et al.
    Bestimmung von logK-Werten macropa-basierter Chelatoren für die stabile Komplexierung von 131Ba, 223/224Ra und 133La
    Nuklearmedizin 62(2023), 149
  • Reissig, F.; Zarschler, K.; Novy, Z. et al.
    Entwicklung alternativer Verbindungen für die PSMA-Therapie mit Actinium-225
    Nuklearmedizin 62(2023), 147
  • Blei, M. K.; Waurick, L.; Reissig, F. et al.
    Equilibrium Thermodynamics of Macropa Complexes with Selected Metal Isotopes of Radiopharmaceutical Interest
    Inorganic Chemistry 62(2023)50, 20699-20709 (10.1021/acs.inorgchem.3c01983)
  • Löser, R.; Kuchar, M.; Wodtke, R. et al.
    Lysyl oxidases as targets for cancer therapy and diagnostic imaging
    ChemMedChem 18(2023)18, e202300331 (10.1002/cmdc.202300331)
  • Crespo, E.; Rodrigues Loureiro, L. R.; Arndt, C. et al.
    Turning an Immunosuppressive Marker Into a T-Cell Activating Signal: Using the RevCAR System to Target Immune Checkpoints
    Human Gene Therapy 54(2023) (10.1089/hum.2023.29252.abstracts)
  • Jósza, T.; Petr, J.; Payne, S. J. et al.
    MRI-based parameter inference for cerebral perfusion modelling in health and ischaemic stroke
    Computers in Biology and Medicine 166(2023), 107543 (10.1016/j.compbiomed.2023.107543)
  • Richter, S.; Steenblock, C.; Lemm, S. et al.
    Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments
    Theranostics 14(2024)1, 17-32 (10.7150/thno.87345)
  • Kegler, A.; Drewitz, L.; Arndt, C. et al.
    A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells
    Frontiers in Immunology 14(2023), 1204543 (10.3389/fimmu.2023.1204543)
  • Gerlach, S.; Balling, F.; Schmidt, A. K. et al.
    Three-dimensional acoustic monitoring of laser-accelerated protons in the focus of a pulsed-power solenoid lens
    High Power Laser Science and Engineering 11(2023), e38 (10.1017/hpl.2023.16)
  • Braun, S.; Jelača, S.; Laube, M. et al.
    Synthesis and In Vitro Biological Evaluation of p-Carborane-based Di-tert-butylphenol Analogs
    Molecules 28(2023), 4547 (10.3390/molecules28114547)
  • Peschke, J.; Bergmann, R.; Mehnert, M. et al.
    FLT3-directed UniCAR T-cell therapy of Acute Myeloid Leukaemia
    British Journal of Haematology 202(2023)6, 1137-1150 (10.1111/bjh.18971)
  • Krutzek, F.; Donat, C.; Ullrich, M. et al.
    Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1
    Cancers 15(2023), 2638 (10.3390/cancers15092638)
  • Ueberham, L.; Gündel, D.; Kellert, M. et al.
    Development of the Highly Affine Carborane-Based Cannabinoid Receptor Type 2 PET Ligand [18F]LUZ5-d8
    Journal of Medicinal Chemistry 66(2023), 5242-5260 (10.1021/acs.jmedchem.3c00195)
  • Wenzel, B.; Schmid, M.; Teodoro, R. et al.
    Radiofluorination of an anionic, azide-functionalized teroligomer by copper-catalyzed azide-alkyne cycloaddition
    Nanomaterials 13(2023)14, 2095 (10.3390/nano13142095)
  • Valentini, C.; Ebert, N.; Koi, L. et al.
    Preclinical trial comparing radiotherapy alone versus standard radiochemotherapy in three human papilloma virus (HPV) negative and three HPV-positive head and neck squamous cell carcinoma (HNSCC) xenograft tumour models.
    Radiotherapy and Oncology 183(2023), 109546 (10.1016/j.radonc.2023.109546)
  • Koevoets, E. W.; Petr, J.; Monninkhof, E. M. et al.
    Effect of physical exercise on brain perfusion in chemotherapy-treated breast cancer patients: a randomized controlled trial (PAM study)
    Journal of Magnetic Resonance Imaging 59(2024)5, 1667-1680 (10.1002/jmri.28967)
  • Wamelink, I. J. H. G.; Azizova, A.; Booth, T. C. et al.
    Brain tumor imaging without gadolinium-based contrast agents: Feasible or Fantasy?
    Radiology 310(2024)2 (10.1148/radiol.230793)
  • Striese, F.; Neuber, C.; Gräßel, S. et al.
    Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5
    International Journal of Molecular Sciences 24(2023)11, 9420 (10.3390/ijms24119420)
  • Pfeifer Serrahima, J.; Zhang, C.; Oberoi, P. et al.
    Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers
    Cancer Immunology, Immunotherapy 72(2023), 2905-2918 (10.1007/s00262-023-03374-x)
  • Braun, S.; Paskas, S.; Laube, M. et al.
    Carborane-based Tebufelone Analogs and their Biological Evaluation In Vitro
    ChemMedChem 18(2023), e202300206 (10.1002/cmdc.202300206)
  • Horst, F. E.; Beyreuther, E.; Bodenstein, E. et al.
    Passive SOBP generation from a static proton pencil beam using 3D-printed range modulators for FLASH experiments
    Frontiers in Physics 11(2023), 1213779. (10.3389/fphy.2023.1213779)
  • Grehn, M.; Mandija, S.; Miszczyk, M. et al.
    STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe
    Europace 25(2023)4, 1284-1295 (10.1093/europace/euac238)
  • Michlikova, S.; Rabasco Meneghetti, A.; Löck, S. et al.
    Radiomics-based prediction of radiosensitivity from preclinical HNSCC histopathology images
    Radiotherapy and Oncology 182(2023)S1, S593 (10.1016/S0167-8140(23)08450-5)
  • Abdelfatah Saleh Hassan, H. A.; Mitwasi, N.; Ullrich, M. et al.
    Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells
    Frontiers in Immunology 14(2023), 1166169 (10.3389/fimmu.2023.1166169)
  • Useini, L.; Komazec, T.; Laube, M. et al.
    Isonimesulide and its carborane analogues as isoform-selective COX inhibitors and antitumor agents
    Advanced Therapeutics 6(2023)8, 2300117 (10.1002/adtp.202300117)
  • Ullrich, M.; Brandt, F.; Löser, R. et al.
    Comparative saturation binding analysis of ⁶⁴Cu-labeled somatostatin analogs using cell homogenates and intact cells
    ACS Omega 8(2023)26, 24003-24009 (10.1021/acsomega.3c02755)
  • Suzuki, Y.; Clement, P.; Dai, W. et al.
    ASL lexicon and reporting recommendations: A consensus report from the ISMRM Open Science Initiative for Perfusion Imaging (OSIPI)
    Magnetic Resonance in Medicine 91(2024), 1743-1760 (10.1002/mrm.29815)
  • Corvino, A.; Reimold, M.; Beyreuther, E. et al.
    miniSCIDOM: a scintillator-based tomograph for volumetric dose reconstruction of single laser-driven proton bunches
    High Power Laser Science and Engineering 12(2024), e17 (10.1017/hpl.2024.1)
  • Reimold, M.; Assenbaum, S.; Beyreuther, E. et al.
    OCTOPOD: single bunch tomography for angular-spectral characterization of laser-driven protons
    High Power Laser Science and Engineering 11(2023), E68 (10.1017/hpl.2023.55)
  • Schieferecke, J.; Gantz, S.; Hoffmann, A. L. et al.
    Investigation of contrast mechanisms for MRI phase signal-based proton beam visualization in water phantoms
    Magnetic Resonance in Medicine 90(2023)5, 1776-1788 (10.1002/mrm.29752)
  • Köseer, A. S.; Di Gaetano, S.; Arndt, C. et al.
    Immunotargeting of Cancer Stem Cells.
    Cancers 15(2023), 1608 (10.3390/cancers15051608)
  • Nguyen Le, T. A.; Zhao, X.; Bachmann, M. et al.
    High-Throughput Gel Microbeads as Incubators for Bacterial Competition Study
    Micromachines 14(2023), 645 (10.3390/mi14030645)
  • Gebauer, B.; Baumann, K.-S.; Fuchs, H. et al.
    Proton dosimetry in a magnetic field: measurement and calculation of correction factors for a plane-parallel ionization chamber
    Medical Physics 51(2024)3, 2293-23005 (10.1002/mp.16797)
  • Plesca, I.; Benešová, I.; Beer, C. et al.
    Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma
    Cancers 14(2022), 1216 (10.3390/cancers14051216)
  • Borodins, O.; Broghammer, F.; Seifert, M. et al.
    Meta-analysis of expression and targeting of cell adhesion associated genes in nine cancer types – a one research lab re-evaluation
    Computational and Structural Biotechnology Journal 21(2023), 2824-2836 (10.1016/j.csbj.2023.04.017)
  • Spautz, S.; Haase, L.; Tschiche, M. et al.
    Comparison of 3D and 4D robustly optimized proton treatment plans for non-small cell lung cancer patients with tumour motion amplitudes larger than 5 mm
    Physics and Imaging in Radiation Oncology 27(2023), 100465 (10.1016/j.phro.2023.100465)
  • Bertschi, S.; Stützer, K.; Berthold, J. et al.
    Potential margin reduction in prostate cancer proton therapy when using prompt gamma imaging for online treatment verification
    Physics and Imaging in Radiation Oncology 26(2023), 100447 (10.1016/j.phro.2023.100447)
  • Fischer, A.; Kloos, S.; Maccio, U. et al.
    Metastatic pheochromocytoma and paraganglioma: somatostatin receptor 2 expression, genetics and therapeutic responses
    Journal of Clinical Endocrinology and Metabolism 108(2023), 2676-2685 (10.1210/clinem/dgad166)
  • Kiß, O.; Scott, P.; Behe, M. et al.
    Highlight selection of radiochemistry and radiopharmacy developments by editorial board
    EJNMMI Radiopharmacy and Chemistry 8(2023), 6 (10.1186/s41181-023-00192-5)
  • Peters, N.; Muren, L. P.
    Towards an integral clinical proton dose prediction uncertainty by considering delineation variation
    Physics and Imaging in Radiation Oncology 21(2022), 134-135 (10.1016/j.phro.2022.03.001)
  • Patil, S.; Tawk, B.; Grosser, M. et al.
    Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy
    Radiotherapy and Oncology 167(2022), 300-307 (10.1016/j.radonc.2021.12.049)
  • Sandoval Bojorquez, D. I.; Janićijević, Ž.; Palestina Romero, B. et al.
    Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies
    ACS Sensors 8(2023)2, 576-586 (10.1021/acssensors.2c01686)
  • Wendler, M.; Kowe, S.
    Strahlenschutzmaßnahmen bei der Anwendung von PET-Nukliden in der Krebsforschung
    Strahlenschutz-Praxis 2(2023), 27-29
  • Witzmann, K.; Raschke, F.; Löck, S. et al.
    Unchanged perfusion in normal-appearing white and grey matter of glioma patients nine months after proton beam irradiation
    Acta Oncologica 62(2023)2, 141-149 (10.1080/0284186X.2023.2176254)
  • Patil, S.; Linge, A.; Grosser, M. et al.
    Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy
    Radiotherapy and Oncology 171(2022), 91-100 (10.1016/j.radonc.2022.04.006)
  • Linke, D.; Donix, L.; Peitzsch, C. et al.
    Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines
    International Journal of Molecular Sciences 24(2023)1, 666 (10.3390/ijms24010666)
  • Peitzsch, C.; Gorodetska, I.; Klusa, D. et al.
    Metabolic regulation of prostate cancer heterogeneity and plasticity
    Seminars in Cancer Biology 82(2022), 94-119 (10.1016/j.semcancer.2020.12.002)
  • Padrela, B. E.; Lorenzini, L.; Collij, L. E. et al.
    Genetic, vascular, and amyloid determinants of cerebral blood flow in a preclinical population
    Journal of Cerebral Blood Flow and Metabolism 43(2023)10, 1726-1736 (10.1177/0271678X231178993)
  • Moyaert, P.; Padrela, B.; Morgan, C. et al.
    Imaging blood-brain barrier dysfunction: A state-of-the-art review from a clinical perspective
    Frontiers in Aging Neuroscience 15(2023), 1132077 (10.3389/fnagi.2023.1132077)
  • Hangel, G.; Schmitz-Abecassis, B.; Sollmann, N. et al.
    Advanced MR Techniques for preoperative Glioma Characterization - Part 2
    Journal of Magnetic Resonance Imaging 57(2023)6, 1676-1695 (10.1002/jmri.28663)
  • Hirschler, L.; Sollmann, N.; Schmitz-Abecassis, B. et al.
    Advanced MR Techniques for preoperative Glioma Characterization - Part 1
    Journal of Magnetic Resonance Imaging 57(2023)6, 1655-1675 (10.1002/jmri.28662)
  • Harrington, S.; Pyche, J.; Andrew, R. B. et al.
    Nemacol is a Small Molecule Inhibitor of C. elegans Vesicular Acetylcholine Transporter with Anthelmintic Potential
    Nature Communications 14(2023), 1816 (10.1038/s41467-023-37452-6)
  • Knieß, T.; Zessin, J.; Mäding, P. et al.
    Synthesis of [18F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist’s perspective
    EJNMMI Radiopharmacy and Chemistry 8(2023)1, 5 (10.1186/s41181-023-00190-7)
  • Brühlmann, S. A.; Walther, M.; Kreller, M. et al.
    Cyclotron-based Production of 67Cu for Radionuclide Theranostics Via the 70Zn(p,α)67Cu Reaction
    Pharmaceuticals 16(2023), 314 (10.3390/ph16020314)
  • Oancea, C.; Granja, C.; Marek, L. et al.
    Out-of-field measurements and simulations of a proton pencil beam in a wide range of dose rates using a Timepix3 detector: Dose rate, flux and LET
    Physica Medica, European Journal of Medical Physics 106(2023), 102529 (10.1016/j.ejmp.2023.102529)
  • Bachmann, L. M.; Hanl, M.; Feller, F. et al.
    Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors
    Molecules 28(2023), 1061 (10.3390/molecules28031061)
  • Kramer, C. S.; Kanagasundaram, T.; Matthias, J. et al.
    Efforts towards PET-activatable red-shifted silicon rhodamines and silicon pyronine dyes
    Pharmaceuticals 16(2023), 401 (10.3390/ph16030401)
  • Classen, S.; Rahlf, E.; Jungwirth, J. et al.
    Partial Reduction in BRCA1 Gene Dose Modulates DNA Replication Stress Level and Thereby Contributes to Sensitivity or Resistance
    Cancers 23(2022)21, 13363 (10.3390/ijms232113363)
  • Sihver, W.; Nitt-Weber, A.-K.; Behrens, S. et al.
    Functionality of a co-culture kidney model: testing the renal barrier with [18F]fluorodeoxyglucose
    Nuclear Medicine and Biology 126-127S(2023), S277
  • Sihver, W.; Liske, N.; Nitt-Weber, A.-K. et al.
    Radiopharmacological comparison of an Al18F- and 68Ga-labeled somatostatin agonist and antagonist in 2D and 3D models of BON-SSTR2 cells
    Nuclear Medicine and Biology 126-127S(2023), 108602
  • Sihver, W.; Nitt-Weber, A.-K.; Behrens, S. et al.
    Assessing the binding affinity of a 64Cu-labeled PSMA ligand in a micro physiological system
    Nuclear Medicine and Biology 127-127S(2023), S24-S25
  • Sihver, W.; Liske, N.; Wodtke, R. et al.
    Comparison of a radiolabeled somatostatin agonist with an antagonist using the SSTR2 expressing cell line BON-1S in 2D and 3D models
    Nuclear Medicine and Biology 108-109(2022)Suppl. 1, P-300
  • Beyreuther, E.; Pawelke, J.; Brand, M. et al.
    Beam pulse structure affects the magnitude of Flash effect in zebrafish embryo
    Radiotherapy and Oncology 170(2022), S69-S70
  • Pape, K.; Lößner, A.; William, D. et al.
    Sensitization of Patient-Derived Colorectal Cancer Organoids to Photon and Proton Radiation by Targeting DNA Damage Response Mechanisms
    Cancers 14(2022), 4984 (10.3390/cancers14204984)
  • Nikulin, P.; Zschaeck, S.; Maus, J. et al.
    A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in [18F]FDG PET/CT
    European Journal of Nuclear Medicine and Molecular Imaging 50(2023), 2751-2766 (10.1007/s00259-023-06197-1)
  • Meric, I.; Alagoz, E.; Hysing, L. et al.
    A hybrid multi-particle approach to range assessment-based treatment verification in particle therapy
    Scientific Reports 13(2023)1, 6709 (10.1038/s41598-023-33777-w)
  • Useini, L.; Mojić, M.; Laube, M. et al.
    Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity
    ChemMedChem 18(2023), e202200583 (10.1002/cmdc.202200583)
  • Sepúlveda, C.; Gebauer, B.; Hoffmann, A. L. et al.
    Experimental dosimetric validation of an open-source treatment planning system for IMPT dose delivery at a horizontal PBS research beamline
    International Journal of Particle Therapy 10(2023)2, 334-334 (10.14338/IJPT-23-PTCOG61-10.2)
  • Metternich, M.; Nazary, H.; Schumacher, D. et al.
    Analyzing the filamentation of MeV-range proton bunches in a laser-driven ion beamline and optimizing their peak intensity
    Physical Review Accelerators and Beams 25(2022), 111301 (10.1103/PhysRevAccelBeams.25.111301)
  • Eulitz, J.; Troost, E. G. C.; Klünder, L. et al.
    Increased relative biological effectiveness and periventricular radiosensitivity in proton therapy of glioma patients
    Radiotherapy and Oncology 178(2023), 109422 (10.1016/j.radonc.2022.11.011)
  • Trenkova, P.; Zhang, Y.; Toshito, T. et al.
    Real-time and online adaptive particle therapy in 10 years: a Delphi consensus analysis
    Radiotherapy and Oncology 182(2023)S1, S1623-S1624 (10.1016/S0167-8140(23)66795-7)
  • Berthold, J.; Pietsch, J.; Piplack, N. et al.
    Detectability of anatomical changes with prompt-gamma imaging: First systematic evaluation of clinical application during prostate-cancer proton therapy
    International Journal of Radiation Oncology Biology Physics 117(2023)3, 718-729 (10.1016/j.ijrobp.2023.05.002)
  • Heerwig, A.; Kick, A.; Sommerfeld, P. et al.
    The Impact of Nε-Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2
    International Journal of Molecular Sciences 24(2023), 1650 (10.3390/ijms24021650)
  • Reimold, M.; Assenbaum, S.; Bernert, C. et al.
    Dosimetry for radiobiological in-vivo experiments at laser plasma-based proton accelerators
    Physics in Medicine and Biology 68(2023), 185009 (10.1088/1361-6560/acf025)
  • Braun, S.; Paskas, S.; Laube, M. et al.
    In vitro Cytostatic Effect on Tumor Cells by Carborane-based Dual Cyclooxygenase-2 and 5-Lipoxygenase Inhibitors
    Advanced Therapeutics 6(2023), 2200252 (10.1002/adtp.202200252)
  • Schulze, S.; Neuber, C.; Möller, S. et al.
    Microdialysis reveals anti-inflammatory effects of sulfated glycosaminoglycanes in the early phase of bone healing
    International Journal of Molecular Sciences 24(2023), 2077 (10.3390/ijms24032077)
  • Voss, J. H.; Al-Hroub, H.; Gedschold, R. et al.
    Imaging of Gαq proteins in mouse and human organs and tissues
    Pharmaceutics 15(2023)1, 57 (10.3390/pharmaceutics15010057)
  • de Planque, C. A.; Petr, J.; Gaillard, L. et al.
    Reply: Discussion Cerebral Blood Flow of the Frontal Lobe in Untreated Children with Trigonocephaly versus Healthy Controls: An Arterial Spin Labeling Study
    Plastic and Reconstructive Surgery 151(2023)3, 527e-528e (10.1097/PRS.0000000000009947)
  • Schlesinger, M.; Jentschel, C.; Pietzsch, H.-J. et al.
    Copper-free click bioconjugation of technetium-99m complexes using strained cyclononyne derivatives
    Dalton Transactions 52(2023), 3024-3032 (10.1039/D2DT03965F)
  • Kiritsis, C.; Shegani, A.; Makrypidi, K. et al.
    Synthesis and preclinical evaluation of rhenium and technetium-99m “4 + 1” mixed-ligand complexes bearing quinazoline derivatives as potential EGFR imaging agents
    Bioorganic & Medicinal Chemistry 73(2022), 117012 (10.1016/j.bmc.2022.117012)
  • Seliger, B.; Jasinski-Bergner, S.; Masssa, C. et al.
    Induction of pulmonary HLA-G expression by SARS-CoV-2 infection
    Cellular and Molecular Life Sciences 79(2022)11, 582 (10.1007/s00018-022-04592-9)
  • Peng, X.; Janićijević, Ž.; Lemm, S. et al.
    Shell engineering in soft alginate-based capsules for culturing liver spheroids
    Biotechnology Journal 18(2023)6, 2200365 (10.1002/biot.202200365)
  • Afshar-Oromieh, A.; Eiber, M.; Fendler, W. et al.
    DGN-Handlungsempfehlung (S1-Leitlinie) PSMA-Liganden-PET/CT in der Diagnostik des Prostatakarzinoms Stand: 01/2022 AWMF-Registernummer: 031-055
    Nuklearmedizin 62(2023)1, 5-19 (10.1055/a-1984-8167)
  • Petr, J.; Keil, V. C.
    Editorial for "Decreased cerebral blood flow in non-hospitalized adults who self-isolated due to COVID-19"
    Journal of Magnetic Resonance Imaging 58(2023)2, 603-604 (10.1002/jmri.28556)
  • Kanasuwan, A.; Deuther-Conrad, W.; Sarasamkan, J. et al.
    Selective a3b4 nicotinic acetylcholine receptor ligand as a potential tracer for drug addiction
    International Journal of Molecular Sciences 24(2023)4, 3614 (10.3390/ijms24043614)
  • Schneider, S.; Stefanowicz, S.; Jentsch, C. et al.
    Reduction of intrafraction pancreas motion using an abdominal corset compatible with proton therapy and MRI
    Clinical and Translational Radiation Oncology 38(2023), 111-116 (10.1016/j.ctro.2022.11.006)
  • Cieslik, P.; Kubeil, M.; Zarschler, K. et al.
    Towards personalized medicine: one chelator for imaging and therapy with lutetium-177 and actinium-225
    Journal of the American Chemical Society 144(2022)47, 21555-21567 (10.1021/jacs.2c08438)
  • Lindner, T.; Bolar, D. S.; Achten, E. et al.
    Current state and Guidance on Arterial Spin Labeling Perfusion MRI in Clinical Neuroimaging
    Magnetic Resonance in Medicine 89(2023)5, 2024-2047 (10.1002/mrm.29572)
  • Gebauer, B.; Pawelke, J.; Hoffmann, A. L. et al.
    Experimental dosimetric characterization of proton pencil beam distortion in a perpendicular magnetic field of an in-beam MR scanner
    Medical Physics 50(2023)11, 7294-7303 (10.1002/mp.16448)
  • Sadeghzadeh, M.; Wenzel, B.; Nikodemus, J. et al.
    Improved protocol for the radiosynthesis of [18F]FTC-146: A potent and selective sigma-1 receptor radioligand
    Journal of Labelled Compounds and Radiopharmaceuticals 66(2023)3, 116-125 (10.1002/jlcr.4018)
  • Starke, S.; Zwanenburg, A.; Leger, K. et al.
    Longitudinal and multimodal radiomics models for head-and-neck cancer outcome prediction
    Cancers 15(2023)3, 673 (10.3390/cancers15030673)
  • Dos, S. J.; Schäfer, M.; Bauder-Wüst, U. et al.
    Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617.
    Frontiers in Chemistry 10(2022), 898692 (10.3389/fchem.2022.898692)
  • Toyohara, J.; Al-Qahtani, M.; Huang, Y. et al.
    Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
    EJNMMI Radiopharmacy and Chemistry 7(2022)1, 25 (10.1186/s41181-022-00177-w)
  • Xu, Y.; Rothe, R.; Voigt, D. et al.
    A self-assembled dynamic extracellular matrix-like hydrogel system with multi-scale structures for cell bioengineering applications
    Acta Biomaterialia 162(2023), 211-225 (10.1016/j.actbio.2023.03.015)
  • Korovina, I.; Vehlow, A.; Temme, A. et al.
    Targeting integrin α2 as potential strategy for radiochemosensitization of glioblastoma
    Neuro-Oncology 25(2022)4, 648-661 (10.1093/neuonc/noac237)
  • Roitzsch, C.; Apolle, R.; Baldus, C. et al.
    Ultrasonic bone cement removal efficiency in total joint arthroplasty revision: A computer tomographic‐based cadaver study
    Journal of Orthopaedic Research 41(2023), 1365-1375 (10.1002/jor.25465)
  • Horst, F. E.; Brand, M.; Hans, S. et al.
    Zebrafish Embryo Model of the FLASH Effect - In Regard to Böhlen et al.
    International Journal of Radiation Oncology Biology Physics 115(2023)4, 1006-1007 (10.1016/j.ijrobp.2022.11.015)
  • Ziegler, C. G.; Riediger, C.; Gruber, M. et al.
    Case report: Incidentally discovered case of pheochromocytoma as a cause of long COVID-19 syndrome
    Frontiers in Endocrinology 13(2022), 967995 (10.3389/fendo.2022.967995)
  • Keuler, T.; Lemke, C.; Elsinghorst, P. W. et al.
    The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents
    ACS Pharmacology & Translational Science 5(2022)11, 1097-1108 (10.1021/acsptsci.2c00097)
  • Penanian, A.; Sommerfeld, P.; Kasprzyk, R. et al.
    A fluorescence anisotropy assay with guanine nucleotides provides access to functional analysis of Gαi1 proteins
    Analytical Chemistry 94(2022)41, 14410-14418 (10.1021/acs.analchem.2c03176)
  • Heuchel, L.; Hahn, C.; Pawelke, J. et al.
    Clinical use and future requirements of relative biological effectiveness: Survey among all European proton therapy centres
    Radiotherapy and Oncology 172(2022), 134-139 (10.1016/j.radonc.2022.05.015)
  • Rabasco Meneghetti, A.; Zwanenburg, A.; Linge, A. et al.
    Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC
    Scientific Reports 12(2022), 16755 (10.1038/s41598-022-21159-7)
  • Pietsch, J.; Khamfongkhruea, C.; Berthold, J. et al.
    Automatic detection and classification of treatment deviations in proton therapy from realistically simulated prompt gamma imaging data
    Medical Physics 50(2023)1, 506-517 (10.1002/mp.15975)
  • Overgaard, J.; Aznar, M. C.; Bacchus, C. et al.
    Personalised radiation therapy taking both the tumour and patient into consideration
    Radiotherapy and Oncology 166(2022), A1-A5 (10.1016/j.radonc.2022.01.010)
  • Peters, N.; Kieslich, A.; Wohlfahrt, P. et al.
    In vivo assessment of tissue-specific radiological parameters with intra- and inter-patient variation using dual-energy computed tomography
    Radiotherapy and Oncology 175(2022), 34-41 (10.1016/j.radonc.2022.07.021)
  • Troost, E. G. C.; Zschaeck, S.; Bütof, R. et al.
    Randomisierte Studie zum Vergleich von Nebenwirkungen nach Protonen- versus Photonen- Strahlentherapie bei Patienten mit fortgeschrittenem nichtkleinzelligen Bronchialkarzinom
    Forum 37(2022), 153-155 (10.1007/s12312-022-01059-7)
  • Brandt, F.; Ullrich, M.; Wodtke, J. et al.
    Enzymological characterization of ⁶⁴Cu-labeled neprilysin substrates and their application for modulating the renal clearance of targeted radiopharmaceuticals
    Journal of Medicinal Chemistry 66(2023)1, 516-537 (10.1021/acs.jmedchem.2c01472)
  • Naumann, M.; Czempiel, T.; Jana Lößner, A. et al.
    Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids
    Cancers 14(2022)15, 3781 (10.3390/cancers14153781)
  • Meattini, I.; Becherini, C.; Boersma, L. et al.
    European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer
    Lancet Oncology 23(2022), e21-e31 (10.1016/S1470-2045(21)00539-8)
  • Löck, S.; Linge, A.; Lohaus, F. et al.
    Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC – Hypothesis generation on a multicentre cohort of the DKTK-ROG
    Radiotherapy and Oncology 169(2022), 8-15 (10.1016/j.radonc.2022.02.009)
  • Knopf, A.-C.; Czerska, K.; Fracchiolla, F. et al.
    Clinical necessity of multi-image based (4DMIB) optimization for targets affected by respiratory motion and treated with scanned particle therapy – A comprehensive review
    Radiotherapy and Oncology 169(2022), 77-85 (10.1016/j.radonc.2022.02.018)
  • Hess, J.; Unger, K.; Maihoefer, C. et al.
    Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer Patients
    Cancers 14(2022), 3745 (10.3390/cancers14153745)
  • Dapper, H.; Belka, C.; Bock, F. et al.
    Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations
    Strahlentherapie und Onkologie 198(2022), 1-11 (10.1007/s00066-021-01861-7)
  • Blankenstein, L. J.; Cordes, N.; Kunz-Schughart, L. A. et al.
    Targeting of p21-Activated Kinase 4 Radiosensitizes Glioblastoma Cells via Impaired DNA Repair
    Cells 11(2022), 2133 (10.3390/cells11142133)
  • Brühlmann, S. A.; Kreller, M.; Pietzsch, H.-J. et al.
    Efficient Production of the PET radionuclide 133La for Theranostic Purposes in Targeted Alpha Therapy using the 134Ba(p,2n)133La Reaction
    Pharmaceuticals 15(2022), 1167 (10.3390/ph15101167)
  • Brandt, F.; Ullrich, M.; Seifert, V. et al.
    Exploring nitric oxide (NO)- releasing celecoxib derivatives as modulators of radioresponse in pheochromocytoma cells
    Molecules 27(2022), 6587 (10.3390/molecules27196587)
  • Jansen, J.; Beyreuther, E.; García-Calderón, D. et al.
    Changes in Radical Levels as a Cause for the FLASH effect: Impact of beam structure parameters at ultra-high dose rates on oxygen depletion in water
    Radiotherapy and Oncology 25(2022), 04245-1 (10.1016/j.radonc.2022.08.024)
  • Wenzel, B.; Fritzsche, S. R.; Toussaint, M. et al.
    Radiosynthesis and preclinical evaluation of an 18F-labeled tri-azolopyridopyrazine-based inhibitor for neuroimaging of the phosphodiesterase 2A (PDE2A)
    Pharmaceuticals 15(2022)10, 1272 (10.3390/ph15101272)
  • Bütof, R.; Häberlein, L.; Jentsch, C. et al.
    Impact of blood parameters and normal tissue dose on treatment outcome in esophageal cancer patients undergoing neoadjuvant radiochemotherapy
    Cancers 14(2022)14, 3504 (10.3390/cancers14143504)
  • Krutzek, F.; Kopka, K.; Stadlbauer, S.
    Development of Radiotracers for Imaging of the PD-1/PD-L1 Axis
    Pharmaceuticals 15(2022), 747 (10.3390/ph15060747)
  • Schindler, L.; Moosbauer, J.; Schmidt, D. et al.
    Development of a neurotensin-derived 68Ga-labeled PET ligand with high in vivo stability for imaging of NTS1 receptor-expressing tumors
    Cancers 14(2022), 4922 (10.3390/cancers14194922)
  • Kramer, C. S.; Greiner, L.; Kopka, K. et al.
    Fluorination of silyl prosthetic groups by fluorine mediated silyl ether linker cleavage: a concept study with conditions applicable in radiofluorination
    EJNMMI Radiopharmacy and Chemistry 7(2022)1, 15 (10.1186/s41181-022-00167-y)
  • Behring, L.; Ruiz-Gomez, G.; Trapp, C. et al.
    Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
    Journal of Medicinal Chemistry 66(2023)6, 3818-3851 (10.1021/acs.jmedchem.2c01360)
  • Raschke, F.; Witzmann, K.; Seidlitz, A. et al.
    Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy
    Clinical and Translational Radiation Oncology 36(2022), 99-105 (10.1016/j.ctro.2022.07.003)
  • Huang, T.; Misko, V.; Caspari, A. et al.
    Electrokinetic Janus micromotors moving on topographically flat chemical patterns
    Communications Materials 3(2022), 60 (10.1038/s43246-022-00282-y)
  • Igbo, B. T.; Linge, A.; Frosch, S. et al.
    Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma
    Clinical and Translational Radiation Oncology 36(2022), 106-112 (10.1016/j.ctro.2022.08.001)
  • Ullrich, M.; Richter, S.; Liers, J. et al.
    Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models
    Theranostics 13(2023)1, 278-294 (10.7150/thno.77918)
  • Teodoro, R.; Gündel, D.; Deuther-Conrad, W. et al.
    Synthesis, Structure–Activity Relationships, Radiofluorination, and Biological Evaluation of [18F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET
    Journal of Medicinal Chemistry 66(2023)20, 13991–14010 (10.1021/acs.jmedchem.3c01035)
  • Krüger-Genge, A.; Köhler, S.; Laube, M. et al.
    Anti-cancer prodrug cyclophosphamide exerts thrombogenic effects on human venous endothelial cells independent of CYP450 activation – relevance to thrombosis
    Cells 12(2023), 1965 (10.3390/cells12151965)
  • Pazderová, L.; Benešová, M.; Havlíčková, J. et al.
    Cyclam with a phosphinate-bis(phosphonate) pendant arm is a bone-targeting carrier of copper radionuclides
    Dalton Transactions 51(2022), 9541-9555 (10.1039/d2dt01172g)
  • Fan, H.; Mutsaerts, H. J. M. M.; Anazodo, U. et al.
    The Open Science Initiative for Perfusion Imaging (OSIPI): ASL Pipeline inventory
    Magnetic Resonance in Medicine 91(2024), 1787-1802 (10.1002/mrm.29869)
  • Dijsselhof, M.; Barboure, M.; Stritt, M. et al.
    The value of arterial spin labelling perfusion MRI in brain age prediction
    Human Brain Mapping 44(2023)7, 2754-2766 (10.1002/hbm.26242)
  • Müller, C. D.; Ruiz-Gómez, G.; Cazzonelli, S. et al.
    Sulfated glycosaminoglycans inhibit transglutaminase 2 by stabilizing its closed conformation
    Scientific Reports 12(2022)1, 13326 (10.1038/s41598-022-17113-2)
  • Reissig, F.; Bauer, D.; Al-Ameed, K. et al.
    Calix[4]crowns with perfluoroalkylsulfonylcarboxamide functions: a complexation approach for heavy group 2 metal ions
    Inorganic Chemistry Frontiers 10(2023), 370-382 (10.1039/d2qi01637k)
  • Anh Nguyen-Le, T.; Bartsch, T.; Wodtke, R. et al.
    Nanochips assisted peptide screening for clinical development of CAR-T cell immunotherapy
    Biosensors and Bioelectronics 206(2022), 114124 (10.1016/j.bios.2022.114124)
  • Latic, N.; Peitzsch, M.; Zupcic, A. et al.
    Long-term excessive dietary phosphate increases arterial blood pressure, activates the renin-angiotensin-aldosterone system, and stimulates sympathetic tone in mice
    Biomedicines 10(2022), 2510 (10.3390/biomedicines10102510)
  • Schulze, S.; Neuber, C.; Möller, S. et al.
    Impact of sulfated hyaluronan on bone metabolism in diabetic Charcot neuroarthropathy and degenerative arthritis
    International Journal of Molecular Sciences 23(2022), 15146 (10.3390/ijms232315146)
  • Lindner, D.; Arndt, C.; Loureiro, L. R. et al.
    Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T cells
    International Journal of Molecular Sciences 23(2022)14, 7922 (10.3390/ijms23147922)
  • Reissig, F.; Zarschler, K.; Novy, Z. et al.
    Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin
    Theranostics 12(2022), 7203-7215 (10.7150/thno.78043)
  • Lorenzini, L.; Ingala, S.; Wink, A. M. et al.
    The Open-Access European Prevention of Alzheimer’s Dementia (EPAD) MRI dataset and processing workflow
    NeuroImage Clinical 35(2022), 103106 (10.1016/j.nicl.2022.103106)
  • Yahya, N.; Linge, A.; Leger, K. et al.
    Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia
    Acta Oncologica 61(2022)7, 856-863 (10.1080/0284186X.2022.2081931)
  • Patil, S. G.; Linge, A.; Hiepe, H. et al.
    A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
    Cancers 14(2022)12, 3031 (10.3390/cancers14123031)
  • Schneider, M.; Linge, A.; Krause, M. et al.
    Importance of long-term follow up to address long-term effectiveness and toxicity of radiotherapy
    Radiotherapy and Oncology 170(2022), 1-3 (10.1016/j.radonc.2022.04.014)
  • Schwarz, F. M.; Schniewind, I.; Besso, M. J. et al.
    Plasticity within Aldehyde Dehydrogenase-Positive Cells Determines Prostate Cancer Radiosensitivity
    Molecular Cancer Research 20(2022), 794-809 (10.1158/1541-7786.MCR-21-0806)
  • Laube, M.; König, J.; Köckerling, M. et al.
    1-(4-Fluorobenzoyl)-9H-carbazole
    Molbank (2022)3, M1430 (10.3390/M1430)
  • Martin, D.; Schreckenbach, T.; Ziegler, P. et al.
    Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium- Radiation Oncology Group (DKTK-ROG)
    Radiotherapy and Oncology 167(2022), 233-238 (10.1016/j.radonc.2021.12.050)
  • Lan, B.; Zeng, S.; Zhang, S. et al.
    CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
    Cancers 14(2022)2, 326 (10.3390/cancers14020326)
  • Ludwig, F.-A.; Lis, C.; Ullrich, M. et al.
    Synthesis of novel PSMA ligands and preclinical evaluation of [99mTc]TcO-ABX474, a radioligand for SPECT imaging of prostate cancer
    Nuclear Medicine and Biology 114-115(2022), S19 (10.1016/S0969-8051(22)02136-9)
  • Tiepolt, S.; Meyer, P. M.; Patt, M. et al.
    PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders
    Journal of Nuclear Medicine 63(2022), 33S-44S (10.2967/jnumed.121.263198)
  • Schieferecke, J.; Gantz, S.; Karsch, L. et al.
    MRI magnitude signal-based proton beam visualisation in water phantoms reflects composite effects of beam-induced buoyant convection and radiation chemistry
    Physics in Medicine and Biology 68(2023), 185002 (10.1088/1361-6560/acf2e0)
  • Schneider, M.; Elisabeth, B.; Suckert, T. et al.
    Combined proton radiography and irradiation for high-precision preclinical studies in small animals
    Frontiers in Oncology 12(2022), 982417 (10.3389/fonc.2022.982417)
  • Hernandez-Garcia, L.; Aramendia, V.; Dai, W. et al.
    Recent technical developments in ASL: A Review of the State of the Art
    Magnetic Resonance in Medicine 88(2022)5, 2021-2042 (10.1002/mrm.29381)
  • Zschaeck, S.; Andela, S. B.; Amthauer, H. et al.
    Correlation Between Quantitative PSMA PET Parameters and Clinical Risk Factors in Non-Metastatic Primary Prostate Cancer Patients
    Frontiers in Oncology 12(2022), 879089 (10.3389/fonc.2022.879089)
  • Arndt, C.; Tunger, A.; Wehner, R. et al.
    Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy
    Frontiers in Pharmacology 14(2023), 970457 (10.3389/fphar.2023.970457)
  • Biancalana, L.; Kubeil, M.; Schoch, S. et al.
    Switching on Cytotoxicity of Water-Soluble Diiron Organometallics by UV Irradiation
    Inorganic Chemistry 61(2022), 7897-7909 (10.1021/acs.inorgchem.2c00504)
  • Bockholt, R.; Paschke, S.; Heubner, L. et al.
    Real-Time Monitoring of Blood Parameters in the Intensive Care Unit: State-of-the-Art and Perspectives
    Journal of Clinical Medicine 11(2022)9, 2408 (10.3390/jcm11092408)
  • Weber, V.; Arnaud, L.; Dukic-Stefanovic, S. et al.
    Novel radioiodinated and radiofluorinated analogues of FT-2102 for SPECT or PET imaging of mIDH1 mutant tumours
    Molecules 27(2022)12, 3766 (10.3390/molecules27123766)
  • Clement, P.; Petr, J.; Dijsselhof, M. B. et al.
    A Beginner’s Guide to Arterial Spin Labeling (ASL) Image Processing
    Frontiers in Radiology 2(2022), 929533 (10.3389/fradi.2022.929533)
  • Liolios, C.; Patsis, C.; Lambrinidis, G. et al.
    Investigation of Tumor Cells and Receptor-Ligand Simulation Models for the Development of PET Imaging Probes Targeting PSMA and GRPR and a Possible Crosstalk between the Two Receptors
    Molecular Pharmaceutics 19(2022)7, 2231-2247 (10.1021/acs.molpharmaceut.2c00070)
  • Hoffmann, L.; Mortensen, H.; Shamshad, M. et al.
    Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: results from eight European centres
    Radiotherapy and Oncology 172(2022), 32-41 (10.1016/j.radonc.2022.04.029)
  • Lemm, S.; Köhler, S.; Wodtke, R. et al.
    Investigation of radiotracer metabolic stability in vitro with CYP-overexpressing hepatoma cell lines
    Cells 11(2022), 2447 (10.3390/cells11152447)
  • Paßler, F.; Belke, L.; Reissig, F. et al.
    Preparation of HOPO-containing lariate ethers based on the diaza-18-crown-6 scaffold
    Chemical Papers 78(2024), 4157-4164 (10.1007/s11696-024-03376-8)
  • Hölscher, T.; Baumann, M.; Kotzerke, J. et al.
    Local control after locally ablative, image-guided radiotherapy of oligometastases identified by Gallium-68-PSMA-Positron Emission Tomography in castration-sensitive prostate cancer patients (OLI-P)
    Cancers 14(2022), 2073 (10.3390/cancers14092073)
  • Mitwasi, N.; Arndt, C.; Loureiro, L. R. et al.
    Targeting CD10 on B-Cell Leukemia Using the Universal CAR T-Cell Platform (UniCAR)
    International Journal of Molecular Sciences 23(2022)9, 4920 (10.3390/ijms23094920)
  • Steinbach, J.; Kopka, K.
    Radiopharmazie des vergangenen Jahrzehnts
    Nuklearmedizin 61(2022)02, 77-79 (10.1055/a-1780-1490)
  • Hafdi, M.; Mutsaerts, H. J.; Petr, J. et al.
    Atherosclerotic risk is associated with cerebral perfusion – a cross-sectional study using arterial spin labelling MRI
    NeuroImage Clinical 36(2022) (10.1016/j.nicl.2022.103142)
  • Sihver, W.; Nitt-Weber, A.-K.; Behrens, S. et al.
    Introducing micro physiological systems to evaluate new radiopharmaceuticals: First attempts with radiolabeled cetuximab
    Current Directions in Biomedical Engineering 8(2022)2, 532-535 (10.1515/cdbme-2022-1136)
  • Reissig, F.; Zarschler, K.; Ludik, M.-C. et al.
    Enhanced blood retention and tumor uptake of PSMA-targeting, 225Ac-labeled radioconjugates
    Nuclear Medicine and Biology 108-109(2022), S30-S31 (10.1016/S0969-8051(22)00103-2)
  • de Roeck, L.; van der Weide, H.; Eekers, D. et al.
    The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation
    Radiotherapy and Oncology 168(2022), 241-249 (10.1016/j.radonc.2022.01.018)
  • Donix, M.; Seidlitz, A.; Buthut, M. et al.
    Subjective memory impairment in glioma patients with curative radiotherapy
    Radiotherapy and Oncology 171(2022), 101-106 (10.1016/j.radonc.2022.04.010)
  • Arndt, C.; Bergmann, R.; Striese, F. et al.
    Development and functional characterization of a versatile radio-/immunotheranostic tool for prostate cancer management
    Cancers 14(2022)8, 1996 (10.3390/cancers14081996)
  • Tripathi, R.; Gluckman, B. J.
    Development of Mechanistic Neural Mass (mNM) Models that Link Physiology to Mean-Field Dynamics
    Frontiers in Network Physiology 2(2022), 911090 (10.3389/fnetp.2022.911090)
  • Yakimovich, A.
    Sequencing meets machine learning to fight emerging pathogens: A preview
    Patterns 3(2022)2, 100448 (10.1016/j.patter.2022.100448)
  • Meyer, F.; M. Engel, A.; K. Krause, A. et al.
    Efficient DNA Repair Mitigates Replication Stress Resulting in Less Immunogenic Cytosolic DNA in Radioresistant Breast Cancer Stem Cells
    Frontiers in Immunology (2022) (10.3389/fimmu.2022.765284)
  • Köseer, A. S.; Loureiro, L. R.; Jureczek, J. et al.
    Validation of CD98hc as a therapeutic target for a combination of radiation and immunotherapies in head and neck squamous cell carcinoma
    Cancers 14(2022)7, 1677 (10.3390/cancers14071677)
  • Wang, K.; Schütze, I.; Gulde, S. et al.
    Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures
    Endocrine-Related Cancer 29(2022)6, 285-306 (10.1530/ERC-21-0355)
  • Hauser, S.; Sommerfeld, P.; Wodtke, J. et al.
    Application of a fluorescence anisotropy-based assay to quantify transglutaminase 2 activity in cell lysates
    International Journal of Molecular Sciences 23(2022)9, 4475 (10.3390/ijms23094475)
  • Wamelink, I. J. H. G.; Kuijer, J. P. A.; Padrela, B. E. et al.
    Reproducibility of 3T APT-CEST in healthy volunteers and brain glioma patients
    Journal of Magnetic Resonance Imaging 57(2023)1, 206-215 (10.1002/jmri.28239)
  • Wang, T.; Zhang, Y.; Zhang, X. et al.
    Synthesis and characterization of the two enantiomers of a chiral sigma-1 receptor radioligand: (S)-(+)- and (R)-(-)-[18F]FBFP
    Chinese Chemical Letters 33(2022)7, 3543-3548 (10.1016/j.cclet.2022.03.099)
  • Useini, L.; Mojic, M.; Laube, M. et al.
    Carboranyl analogues of mefenamic acid and their biological evaluation
    ACS Omega 7(2022), 24282-24291 (10.1021/acsomega.2c01523)
  • Kubeil, M.; Santana Martinez, I. I.; Bachmann, M. et al.
    Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives
    Pharmaceuticals 15(2022), 432 (10.3390/ph15040432)
  • Eder, A.; Matthias, J.; Schäfer, M. et al.
    A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer
    Pharmaceuticals 15(2022)3, 267 (10.3390/ph15030267)
  • Braune, A.; Oehme, L.; Freudenberg, R. et al.
    Comparison of Image Quality and Spatial Resolution Between 18F, 68Ga and 64Cu Phantom Measurements Using a Digital Biograph Vision PET/CT
    EJNMMI Physics 9(2022)1, 58 (10.1186/s40658-022-00487-7)
  • Rogasch, J.; Hofheinz, F.; van Heek, L. et al.
    Influences on PET Quantification and Interpretation
    Diagnostics 12(2022)2, 451 (10.3390/diagnostics12020451)
  • Gringmuth, M.; Walther, J.; Greiser, S. et al.
    Enhanced survival of high-risk medulloblastoma-bearing mice after multimodal treatment with radiotherapy, decitabine, and abacavir
    International Journal of Molecular Sciences 23(2022)7, 3815 (10.3390/ijms23073815)
  • Vehlow, A.; Cordes, N.
    Growth factor receptor and β1 integrin signaling differentially regulate basal clonogenicity and radiation survival of fibroblasts via a modulation of cell cycling
    In Vitro Cellular & Developmental Biology - Animal 58(2022), 169-178 (10.1007/s11626-022-00656-z)
  • Karsch, L.; Pawelke, J.; Brand, M. et al.
    Beam pulse structure and dose rate as determinants for the Flash effect observed in zebrafish embryo
    Radiotherapy and Oncology 173(2022), 49-54 (10.1016/j.radonc.2022.05.025)
  • Baraban, L.; Seichepine, F.; Sessi, V. et al.
    Multisite Dopamine Sensing with Femtomolar Resolution Using a CMOS Enabled Aptasensor Chip
    Frontiers in Neuroscience 16(2022), 875656 (10.3389/fnins.2022.875656)
  • Bauer, J.; Hildebrandt, M.; Baumgartl, M. et al.
    Quantitative assessment of radionuclide production yields in in-beam1 and offline PET measurements at different proton irradiation facilities
    Physics in Medicine and Biology 67(2022)15, 155001 (10.1088/1361-6560/ac7a89)
  • Reissig, F.; Mamat, C.
    Strained Ammonium Precursors for Radiofluorinations
    ChemistryOpen 11(2022), e202200039 (10.1002/open.202200039)
  • Vaz, S.; Adam, J.; Bolton Delgado, R. et al.
    Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer
    Radiotherapy and Oncology 168(2022), 37-39 (10.1016/j.radonc.2021.12.048)
  • Di Perri, D.; Hofstede, D.; Postma, A. et al.
    Development of explanatory movies for the delineation of new organs at risk in neuro-oncology
    Clinical and Translational Radiation Oncology 33(2022), 112-114 (10.1016/j.ctro.2022.02.005)
  • Underwood, T.; McNamara, A.; Appelt, A. et al.
    A systematic review of clinical studies on proton Relative Biological Effectiveness (RBE)
    Radiotherapy and Oncology 175(2022), 79-92 (10.1016/j.radonc.2022.08.014)
  • Mitrach, F.; Schmid, M.; Toussaint, M. et al.
    Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
    Pharmaceutics 14(2022)2, 326 (10.3390/pharmaceutics14020326)
  • Shahzadi, I.; Zwanenburg, A.; Lattermann, A. et al.
    Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models
    Scientific Reports 12(2022), 10192 (10.1038/s41598-022-13967-8)
  • Bernardes, E.; Caravan, P.; van Dam, M. et al.
    Highlight selection of radiochemistry and radiopharmacy developments by editorial board
    EJNMMI Radiopharmacy and Chemistry 7(2022)1, 9 (10.1186/s41181-022-00162-3)
  • Berthold, J.; Hueso González, F.; Wohlfahrt, P. et al.
    Prompt-gamma based treatment verification: Multi-institutional benchmark experiment of a prompt-gamma-imaging and a prompt-gamma-spectroscopy prototype system using an anthropomorphic head phantom
    International Journal of Particle Therapy 9(2023)4, 306-470 (10.14338/IJPT-23-PTCOG60-9.4)
  • Chai, X.-N.; Ludwig, F.-A.; Müglitz, A. et al.
    A pharmacokinetic and metabolism study of the TRPC6 inhibitor SH045 in mice by LC-MS/MS
    International Journal of Molecular Sciences 23(2022)7, 3635 (10.3390/ijms23073635)
  • Clauß, O.; Schäker-Hübner, L.; Wenzel, B. et al.
    Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [¹⁸F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain
    Pharmaceuticals 15(2022)3, 324 (10.3390/ph15030324)
  • Donix, L.; Erb, H. H.; Peitzsch, C. et al.
    Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines
    Journal of Cancer Research and Clinical Oncology 148(2022), 1313-1324 (10.1007/s00432-022-03914-5)
  • Müller, J.; Leger, S.; Zwanenburg, A. et al.
    Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical setting
    Radiotherapy and Oncology 169(2022), 96-104 (10.1016/j.radonc.2022.02.020)
  • Nickl, R.; Hauser, S.; Pietzsch, J. et al.
    Significance of pulmonary endothelial injury and the role of cyclooxygenase-2 and prostanoid signaling
    Bioengineering 10(2023)1, 117 (10.3390/bioengineering10010117)
  • Schniewind, I.; Hadiwikarta, W. W.; Grajek, J. et al.
    Cellular plasticity upon proton irradiation determines tumor cell radiosensitivity
    Cell Reports 38(2022)8, 110422 (10.1016/j.celrep.2022.110422)
  • Michler, E.; Hilliger, S.; Kopka, K. et al.
    11C-Methionine Uptake in the Lactating Human Breast
    Clinical Nuclear Medicine 47(2022)1, e66-e67 (10.1097/RLU.0000000000003836)
  • Hendrikse, H.; Kiß, O.; Kunikowska, J. et al.
    EANM Position on the In-House Preparation of Radiopharmaceuticals
    European Journal of Nuclear Medicine and Molecular Imaging 49(2022)4, 1095-1098 (10.1007/s00259-022-05694-z)
  • Gündel, D.; Deuther-Conrad, W.; Ueberham, L. et al.
    Structure-Based Design, Optimization and Development of [18F]LU13, a novel radioligand for CB2R Imaging in the Brain with PET
    Journal of Medicinal Chemistry 65(2022)13, 9034-9049 (10.1021/acs.jmedchem.2c00256)
  • Vaz, S.; Adam, J.; Delgado Bolton, R. et al.
    Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2‑[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
    European Journal of Nuclear Medicine and Molecular Imaging 49(2022), 1386-1406 (10.1007/s00259-021-05624-5)
  • In’T Ven, L.; Compter, I.; van Eijsden, K. et al.
    Pre-treatment visualization of predicted radiation-induced acute alopecia in brain tumour patients
    Clinical and Translational Radiation Oncology 33(2022), 106-111 (10.1016/j.ctro.2022.02.003)
  • Bütof, R.; Hönscheid, P.; Aktar, R. et al.
    Orthotopic glioblastoma models for evaluation of the CTV concept
    Cancers 14(2022), 4559 (10.3390/cancers14194559)
  • Xu, Y.; Patino Gaillez, M.; Zheng, K. et al.
    A self-assembled matrix system for cell-bioengineering applications in different dimensions, scales, and geometries
    Small 18(2022), 2104758 (10.1002/smll.202104758)
  • Clement, P.; Castellaro, M.; Okell, T. W. et al.
    ASL-BIDS, the brain imaging data structure extension for arterial spin labeling
    Scientific Data 9(2022), 543 (10.1038/s41597-022-01615-9)
  • Gyanwali, B.; Seng Tan, C.; Petr, J. et al.
    Arterial Spin-Labeling Parameters and Their Associations with Risk Factors, Cerebral Small-Vessel Disease, and Etiologic Subtypes of Cognitive Impairment and Dementia
    American Journal of Neuroradiology 43(2022)10, 1418-1423 (10.3174/ajnr.A7630)
  • Gyanwali, B.; Mutsaerts, H. J. M. M.; Seng Tan, C. et al.
    Association of arterial spin labeling parameters with cognitive decline, vascular events and mortality in a memory-clinic sample
    American Journal of Geriatric Psychiatry 30(2022)12, 1298-1309 (10.1016/j.jagp.2022.06.007)
  • Abdulrahman, H.; Hafdi, M.; Mutsaerts, H. J. M. M. et al.
    Cerebral perfusion and the risk for cognitive decline and dementia in community dwelling older people
    Cerebral Circulation, Cognition and Behavior 3(2022), 100125 (10.1016/j.cccb.2022.100125)
  • Noelia Chao, M.; Chezal, J.-M.; Debiton, E. et al.
    A convenient route to new (radio)fluorinated and (radio)iodinated cyclic tyrosine analogues.
    Pharmaceuticals 15(2022)2, 162 (10.3390/ph15020162)
  • Aepler, J.; Wodtke, J.; Wodtke, R. et al.
    The role of transglutaminase 2 in the radioresistance of melanoma cells
    Cells 11(2022), 1342 (10.3390/cells11081342)
  • Schellhammer, S.; Wiedkamp, J.; Löck, S. et al.
    Multivariate statistical modelling to improve particle treatment verification: Implications for prompt gamma-ray timing
    Frontiers in Physics 10(2022), 932950 (10.3389/fphy.2022.932950)
  • Bechmann, N.; Calsina, B.; Richter, S. et al.
    Therapeutic Potential of Nitric Oxide releasing Selective Estrogen Receptor Modulators (NO-SERMs) in Malignant Melanoma
    Journal of Investigative Dermatology 142(2022), 2217-2227 (10.1016/j.jid.2021.12.028)
  • Southcott, L.; Whetter, J. N.; Wharton, L. et al.
    Bis(amido)bis(oxinate)diamine ligands for theranostic radiometals
    Journal of Inorganic Biochemistry 231(2022), 111789 (10.1016/j.jinorgbio.2022.111789)
  • Gillings, N.; Hjelstuen, O.; Behe, M. et al.
    EANM Guideline on Quality Risk Management for radiopharmaceuticals
    European Journal of Nuclear Medicine and Molecular Imaging 49(2022), 3353-3364 (10.1007/s00259-022-05738-4)
  • Zippel, C.; Ermert, J.; Patt, M. et al.
    Cyclotrons operated for Nuclear Medicine and Radiopharmacy in the German speaking D-A-CH countries: An update on current status and trends
    Frontiers in Nuclear Medicine 2(2022), 850414 (10.3389/fnume.2022.850414)
  • Lai, T. H.; Wenzel, B.; Moldovan, R.-P. et al.
    Automated radiosynthesis of the adenosine A2A receptor-targeting radiotracer [18F]FLUDA
    Journal of Labelled Compounds and Radiopharmaceuticals 65(2022), 162-166 (10.1002/jlcr.3970)
  • Berthold, J.; Hübinger, L.; Piplack, N. et al.
    Treatment verification with prompt-gamma imaging: Detection sensitivity of anatomical changes in HNC
    Radiotherapy and Oncology 170(2022)Supplement, S837-S838 (10.1016/S0167-8140(22)02725-6)
  • Gündel, D.; Toussaint, M.; Lai, T. H. et al.
    Quantitation of the A2A adenosine receptor density in the striatum of mice and pigs with [18F]FLUDA by positron emission tomography
    Pharmaceuticals 15(2022), 516 (10.3390/ph15050516)
  • Gündel, D.; Lai, T. H.; Dukic-Stefanovic, S. et al.
    Non-invasive assessment of locally overexpressed human adenosine 2A receptors in the heart of transgenic mice
    International Journal of Molecular Sciences 23(2022)3, 1025 (10.3390/ijms23031025)
  • Gündel, D.; Toussaint, M.; Moldovan, R.-P. et al.
    Evaluation of [18F]RM273 for sigma2-receptor imaging in an experimental orthotopic glioblastoma model
    Nuclear Medicine and Biology 108-109(2022)Suppl., S184 (10.1016/S0969-8051(22)00384-5)
  • Pietsch, J.; Nick, P.; Berthold, J. et al.
    Prompt-gamma imaging for prostate cancer proton therapy: CNN-based detection of anatomical changes
    Radiotherapy and Oncology 170(2022)Supplement, 546-548 (10.1016/S0167-8140(22)02642-1)
  • Zschaeck, S.; Weingärtner, J.; Lombardo, E. et al.
    18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization
    Frontiers in Oncology 12(2022), 870319 (10.3389/fonc.2022.870319)
  • Spautz, S.; Jakobi, A.; Meijers, A. et al.
    Experimental validation of 4D log file-based proton dose reconstruction for interplay assessment considering amplitude-sorted 4DCTs
    Medical Physics 49(2022), 3538-3549 (10.1002/mp.15625)
  • Zheng, Z.; Tsvetkov, D.; Bartolomaeus, T. et al.
    Role of TRPC6 in Kidney Damage after Acute Ischemic Kidney Injury
    Scientific Reports 12(2022), 3038 (10.1038/s41598-022-06703-9)
  • Reissig, F.; Runge, R.; Naumann, A. et al.
    Cisplatin - A more Efficient Drug in Combination with Radionuclides?
    Nuklearmedizin 61(2022)04, 325-332 (10.1055/a-1759-1749)
  • Soltwedel, J.; Suckert, T.; Beyreuther, E. et al.
    Slice2Volume: Fusion of multimodal medical imaging and light microscopy data of irradiation-injured brain tissue in 3D
    Radiotherapy and Oncology 182(2023), 109591 (10.1016/j.radonc.2023.109591)
  • Blumberg, M.; Al-Ameed, K.; Eiselt, E. et al.
    Preparation of calix[4]arenes for chelation of selected divalent cations
    Molecules 27(2022)5, 1478 (10.3390/molecules27051478)
  • Berthold, J.; Piplack, N.; Traneus, E. et al.
    Treatment verification with prompt-gamma-imaging: Detection of anatomical changes in prostate-cancer proton therapy
    International Journal of Particle Therapy (2022) (10.14338/IJPT-22-PTCOG59-9.3)
  • de Planque, C. A.; Petr, J.; Gaillard, L. et al.
    Cerebral blood flow of the frontal lobe in untreated children with trigonocephaly vs healthy controls: an arterial spin labeling study
    Plastic and Reconstructive Surgery 149(2022)4, 931-937 (10.1097/PRS.0000000000008931)
  • Haase-Kohn, C.; Laube, M.; Donat, C. et al.
    CRISPR/Cas9 mediated knockout of cyclooxygenase-2 gene inhibits invasiveness in A2058 melanoma cells
    Cells 11(2022)4, 749 (10.3390/cells11040749)